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ABSTRACT 
The effect of xylazine on t he r e trograde flow of spermatozoa into the 
urinary bladder of rams (Part I, Experiments 1 , 2, and 3 ) , and the effect 
of flushing the vasa deferentia at the time of vasectomy on the rate of 
clearance of spermatozoa from the electroejaculates of vasectomized rams 
( Part II , Experiment 4) were studied. In Experiment 1, the spermatozoal 
concentration , but not the volume or the total number of spermatozoa of the 
electroejaculate, was decreased (P-0 . 015) by treatment with xylazine before 
electroejaculation (EE) . Administration of xylazine to rams before EE 
increased (P-0.017) the retrograde flow of spermatozoa into the bladder. 
Administration of xylazine to sexually rested rams induced urinary losses 
of spermatozoa that were not different (P>O.l) from those induced by EE or 
by giving xylazine before EE. In Experiment 2, treatment of sexually 
rested rams with xylazine decreased (P-0.0001) the volume of urine voided 
during micturition and the frequency of micturitions within 60 minutes of 
treatment. Spermatozoal concentration and total number of spermatozoa in 
the urine obtained during micturition were not different between control 
and xylazine-treated rams. In Experiment 3, urine was withdrawn from a 
catheter implanted in the urinary bladder. Xylazine increased ( P-0.006 ) 
the tota l volume of u r i n e obtained from the bladder within 60 minutes of 
treatment. Xy l azine significantly increased the spermatozoal concentration 
(P-0 . 048) and total numbe r of spermatozoa (P-0.009) in the urine obtained 
from the bladder of sexually rested rams. Results of Part I indicate that 
xylazine induced retrograde flow of spermatozoa into the urinary bladder 
when administered to sexually rested rams, and that administration of 
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xylazine to rams before EE increased the retrograde flow of spermatozoa 
into the bladder . Because of the magnitude of spermatozoal losses in urine 
induced by xylazine when given to sexually rested rams or when given to 
rams before EE, the use of xylazine as a sedative to restrain rams during 
EE is not recommended. 
In Experiment 4, flushing the vasa deferentia at the time of 
vasectomy reduced to zero the number of viable, motile spermatozoa in the 
electroejaculates by post-vasectomy day 7, whereas the number of viable and 
motile spermatozoa was reduced to zero by post-vasectomy day 14 for the 
control rams, which were vasectomized but not flushed. The total number of 
spermatozoa and number of intact spermatozoa in the electroejaculates were 
significantly less for the treated than for the control rams on post-
vasectomy day 3 (P<0.0001) and again on post-vasectomy day 7 (P<0.002). 
However, none of the rams from either treatment group produced two 
consecutive azoospermic electroejaculates during the experimental period 
( up to post-vasectomy day 63). Flushing the vasa deferentia at the time of 
vasectomy may have clinical applications since this technique resulted in 
the obtainment of electroejaculates devoid of viable and motile spermatozoa 
one week earlier than vasectomy alone. 
Publication: 
Hernandez FI, Dooley MP , Pineda MH. Effect of xylazine on the 
retrograde flow of spermatozoa into the urinary bladder of rams . Beef & 
Sheep Research Report - Iowa State University, 1992, pp. 160-164, A. S. 
Leaflet R938. 
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INTRODUCTION 
For the purpose of presentation of the results of studies performed 
for the Master of Science degree , this Thesis is divided into two parts. 
In Part I, the results of three experiments (Experiments 1, 2, and 3) 
conducted to determine effects of xylazine on spermatozoa! displacement and 
retrograde flow of spermatozoa into the urinary bladder of rams are 
described. Experiment 1 was performed to determine whether administration 
of xylazine to rams before seminal collection affected spermatozoal 
displacement during electroejaculation. In subsequent experiments , 
xylazine was administered to sexually rested rams and the magnitude of 
urinary spermatozoal losses was determined for urine obtained during 
micturition (Experiment 2) and for urine obtained from a catheter implanted 
in the urinary bladder (Experiment 3). 
In Part II, the rate of clearance of spermatozoa from the ejaculates 
of vasectomized rams was determined. Experiment 4 was designed to 
determine the effects of flushing the vasa deferentia at the time of 
vasectomy on the rate of spermatozoal clearance in rams and on the 
viability of spermatozoa in post-vasectomy ejaculates. 
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PART I. EFFECT OF XYLAZINE ON THE RETROGRADE FLOW OF 
SPERMATOZOA INTO THE URINARY BLADDER OF RAMS 
It is now evident that retrograde flow of spermatozoa into the 
urinary bladder occurs in several animal species when semen is collected 
with an artificial vagina (AV), during electroejaculation (EE), or even 
during mating. Urinary losses caused by the retrograde flow of spermatozoa 
into the bladder decrease the number of spermatozoa in the ejaculate. 
Thus, retrograde flow of spermatozoa into the bladder during seminal 
co llection should be evaluated as a component of the breeding soundness 
examination of rams and other domestic males. Sires releasing oligospermic 
ejaculates are often culled. However, retrograde flow of spermatozoa into 
the bladder could be a temporary condition and, therefore, its magnitude 
should be determined at each breeding soundness examination, particularly 
for genetically valuable males. 
Xylazine is often used as a sedative in c linical practice in 
Veterinary Medicine to restrain animals. Tranquilizers have been used to 
restrain unmanageable bulls during EE, and xylazine may, under certain 
conditions, be used for the same purpose in rams. However, xylazine may 
affect the electroejaculatory response in rams , because it has been shown 
that xylazine induces retrograde flow of spermatozoa into the bladder of 
dogs (1). 
Part I of this study was designed to determine whether xylazine: a) 
affects the electroejaculatory response of rams and b) induces retrograde 
displacement of spermatozoa from their sites of storage in the epididyrnides 
and vasa deferentia to the urethra and from the urethra into the urinary 
bladder of sexually rested rams. 
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Literature Review 
For all the domestic species studied to date, the daily sperm output 
(DSO) is lower (2-5) than the daily sperm production (DSP). This 
discrepancy has been attributed to losses of spermatozoa in the equipment 
used for seminal collection (2), overestimation of the DSP (2,3), or 
phagocytosis and reabsorption of spermatozoa in the excurrent ducts (6-8). 
Although phagocytosis of spermatozoa by leukocytes has been observed (9) in 
the excurrent ducts after vasectomy, studies on laboratory rodents (9) did 
not support the reabsorption hypothesis. For the ram, the DSP per gram of 
testis was estimated (5) as 25 ± 2 x 106 spermatozoa, whereas the DSO per 
gram of testis was only 7 ± 1 x 106 spermatozoa. The mean daily sperm 
output estimated (10) from the number of spermatozoa eliminated daily in 
the urine of sexually rested rams was 96.6% of the estimated daily sperm 
production. 
Urinary losses of spermatozoa have been long known to occur in rams 
( 10-16) , bulls (6), rabbits ( 17), rats (18), and men (19,20), and the 
number of spermatozoa voided in the urine decreased during periods of 
frequent ejaculations in rams (11,16), bulls (6) and rabbits (17). 
Spermatozoa were observed (16) in the urine obtained from a catheter 
implanted in the bladder of two rams when semen was collected with an AV. 
Studies performed to determine spermatozoal losses in the urine have either 
failed to recognize the retrograde flow of spermatozoa into the urinary 
bladder and attributed (2,3,6,10-13,17-21) the losses to the washing out by 
the urine of spermatozoa left in the urethra during ejaculation or between 
ejaculations, or did not determine for each animal the magnitude of the 
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ejaculatory retrograde flow of spermatozoa (14-16). Spermatozoa have been 
recovered from the urinary bladder of rams during sexual rest ( 14-16 ), 
before EE (22,23), and before seminal col lection with an AV (23). 
Spermatozoal losses due to retrograde flow of spermatozoa into the urinary 
bladder occur during EE in anesthetized ca ts (24-26), lion-tailed macaques 
(27) and gorillas (28), during EE in non-anesthet ized bulls (29) and rams 
(22,23), during collection of semen with an AV in rams (23) and cats (26), 
during collection of semen by digital manipu lation of the penis in dogs 
( 1 ,25), a nd during natural mating in cats (26) . Retr ograde e jaculation , 
with no antegrade displacement of spermatozoa, has been repo rte d in a dog 
(30) and in men (31-34). 
In the absence of ejaculation, daily pro duced spermatozoa are 
displaced from the caudae epididymides and vasa deferentia into the pelvic 
urethra (3,8). In rabbits (35,36) and rams (7, 14-16), there i s a constant 
transport of spermatozoa t hrough the vasa deferentia during a nd between 
ejaculations. Contractility of t h e caudae epididymides and vasa deferentia 
was s hown during seminal emission in ra ts (37) . In rabbits (35,36) the 
vasa deferentia participates act i vely in es t ablishing a decreasing gradient 
of spermatozoal concentration toward the distal ( ure t hral ) end of the vas 
deferens during sexual rest. Radiopaque dye injecte d into the e pididy mis 
of rabbits (36) moved slowly during sexual r est until reaching the urethra, 
but it was transported faster from the ep ididymis into the vas during 
sexual arousal. During sexual r est t hat fo llowe d sexual stimulation, with 
or without ejaculation, the radiopaque dye in the vas was dis place d back 
into the epididymis (36). Contractility o f the vasa deferentia and 
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epididymides of r ams (38) can be initiated by stimuli elicited during 
penile intromission, by increased intralurninal pressure in the vasa, or by 
administration of oxytoc in, vasopressin, or epinephrine. The contractile 
effect on the vasa deferentia and epididymides (38) was more intense for 
oxytocin and epinephrine than for vasopressin, and more prolonged for 
oxytocin and vasopressin than for epinephrine. Oxytocin, but not 
epinephrine, increased (39) the spermatozoal output of rams when semen was 
collected with an AV. 
The estimated resistance opposed by the pars spongiosa of the urethra 
of rams to fluid displacement (16) was relatively high (550 to 1740 mm Hg). 
In anesthetized rats (40), micturition occurred when the intravesicular 
pressure was increased by saline infusion to 20 mm Hg to overcome the 
urethral resistance to outflow. Fluid flushed through the vasa deferentia 
of anesthetized dogs and cats at the time of vasectomy (25) flowed into the 
urinary bladder. Thus, flow of spermatozoa, and possibly other seminal 
components, into the urinary bladder during and between ejaculations may 
follow a pathway of least r es i stance (22 , 25). 
Retrograde flow of fluid into the bladder was observed when 
radiopaque fluid was injected into the scrotal vas deferens of marsupials 
(41) or men (42). Radiopaque fluid flowed into the bladder of anesthetized 
rams (43,44) when the fluid was deposited directly into the urethra or 
when the volume of the radiopaque fluid infused into the scrotal vas 
deferens was sufficient to fill the vas and spill into the pelvic urethra. 
Radiopaque fluid infused into the scrotal vas deferens of anesthetized rams 
was also displaced into the urethra during electrical stimulation with an 
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electroejaculator, and a portion of the radiopaque fluid flowed into the 
bladder (43,44). These results , again, suggest that the pathway of least 
resistance is for the retrograde flow of spermatozoa and possibly seminal 
fluid into the bladder. Furthermore, retrograde flow of spermatozoa into 
the bladder in sexually rested animals or between ejaculations may be a 
physiological mechanism to discard aged spermatozoa (22,25). 
The percentage of retrograde flow, defined as the percentage of the 
total number of spermatozoa displaced from the sites of storage in the 
e pididymides and vasa deferentia during ejaculation or EE that flowed into 
the urinary bladder, varies among animals and method of seminal collection 
(1,22-27,29). The overall mean percentages of retrograde flow during EE in 
rams (22) were 28.3 t and 20.1 t for the nonbreeding and breeding seasons, 
respectively. The percentage of retrograde flow of spermatozoa into the 
bladder of rams (23) during the nonbreeding season tended to be smaller 
when semen was collected with an AV (overall mean± SD - 2.7 ± 4.8 %) than 
when semen was collected by EE (15.3 ± 29.9 %) from the same rams. 
The spermatozoal concentration in sequential samples of urine 
collected during the first micturition after electroejaculation of bulls 
( 29) and rams (22,23), or in sequential samples of urine obtained by 
cystocentesis from dogs after ejaculation (1) was not different between 
consecuti ve samples, indicating that the spermatozoa had mixed with the 
urine in t h e bladder before micturition o r cystocentesis . This offers a 
non-invasive approach to determine the percentage of retrograde flow of 
spermatozoa into the bladder during the preceding ejaculation (22,23,29). 
Administration of furosemide to rams, prior to seminal collection with an 
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AV, did not affect the ejaculatory response, volume of ejaculate and total 
number of spermatozoa in the ejaculate, total number of spermatozoa in the 
post-ejaculation urine, or the percentage of retrograde flow of spermatozoa 
into the bladder (23). Thus, furosemide can be used to induce micturition 
to facilitate the collection of sequential samples of urine as a non-
invasive approach to determine the percentage of retrograde flow in rams 
and possibly other species. Furosemide exerts its diuretic effect through 
inhibition of reabsorption of sodium chloride in the ascending limb of 
Henle's loop of the nephron (45) . An additional experimental or clinical 
advantage for the use of furosemide is that the motility of spermatozoa in 
the urine may be prolonged (23) because spermatozoa are exposed to a less 
concentrated urine when furosemide is used. The motility of spermatozoa in 
samples of human ejaculates ceased when samples were mixed with fresh human 
urine (46). Neutralization of urinary pH did not protect the spermatozoa 
from this effect unless the osmolarity of the urine was also isotonically 
adjusted (46). 
Marked differences in the spermatozoal output among animals of the 
same species may be conditioned by a variable retrograde flow of 
spermatozoa into the bladder during seminal collection (22). Because the 
spermatozoal concentration in the urine collected during sexual rest or 
before ejaculation in bulls (29), cats (26), dogs (1), rams (22,23), and 
possibly other species is negligible or the urine is azoospermic, the 
determination of the total number of spermatozoa in the ejaculate and in 
the urine recovered immediately after ejaculation should provide an 
accurate (1,22) estimation of the total number of spermatozoa displaced 
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during the preceding ejaculation . This in turn would provide a non-
invasive means to monitor DSP over extended periods of time. 
Administration of xylazine to sexually rested dogs induced retrograde 
flow of s permatozoa into the urinary bladder (1). This finding indicates 
that spermatozoal disp l acement and retrograde flow of spermatozoa into the 
urinary bladder can be induced pharmacologically in the absence of sexual 
stimulation or ejaculation. In addition, xylazine induced ejaculation ex 
copula in horses with or without sexual pre-stimulation in 39% or 14% of 
the trials performed, respectively (47). Xylazine is an o 2 -adrenoreceptor 
agonist that depresses the CNS in dogs (48) and sheep (49,50) . Alpha2 -
adrenorecepto r agonists induce diuresis by reversing vasopressin-induced 
water retention (51). It has not been determined whether the diuretic 
effect of o 2 -adrenoreceptor agonists is exerted centrally through 
inhibition of release of vasopressin or peripherally through a direct 
antagonism of the renal actions of vasopressin (5 1 ). Xylazine induced a 
diuresis that lasted for 5 hours in cattle, and the effect was greater 
during the first 2 hours after xylazine was given (52). Peripherally , 
xylazine decreases urethral pressure and resistance to flow of urine in 
male and female dogs, without altering intravesicular pressure (53). 
Alpha-adrenoreceptors media te the r esponse to adrenergic agonists for 
the contraction of the vas deferens (54-56), whereas ~-adrenoreceptors are 
thought to mediate relaxation (56). Mediated by o 2 -adrenoreceptors, 
xylazine induced a pre-synaptic inhibition of the contractile response 
elicited by neural stimulation of the isolated vas deferens of rats, 
whereas o 1 -adrenoreceptor agonists potentiated the pre-existing, neurally 
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stimulated contraction (54). Alpha-adrenoreceptors are thought (31) to 
participate in the contraction of the trigone and sphincter of the urinary 
bladder during ejaculation. Beta-adrenoreceptors predominate (57) in the 
body of the bladder of 3 to 4 month old male l ambs, whereas a 1 -
adrenoreceptors predominate in the caudal portion of the bladder (bladder 
base). During sympathetic stimulation, the bladder base of sheep 
constricts by activation of the a 1 -receptors and the detrusor muscle 
relaxes by activation of ~ 1 and ~2 -receptors, contributing to the filling 
of the bladder during the storage phase of micturition (57). In horses 
(58), a 1 -adrenoreceptors mediate the contraction of the urethra, a 1 - and 
a 2 -adrenoreceptors mediate prostatic contractions, and ~2 -adrenoreceptors 
mediate the relaxation of both organs. In men ( 59), a-adrenergic agonists 
have been used to prevent retrograde ejaculation. The combined treatment 
with a ~ - adrenoreceptor antagonist and an a-adrenoreceptor agonist 
increased spermatozoal output in dogs ( 60) and horses (61) . Tolazoline, an 
a 2 -adrenoreceptor antagonist, reverses the xylazine-induced bradycardia, 
tachypnea and CNS depression in sheep ( 49 ,50). 
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PART II. CLEARANCE OF SPERMATOZOA FROM ELECTROEJACUI.ATES OF VASECTOMIZED 
RAMS AFTER FLUSHING THE VASA DEFERENTIA AT THE TIME OF VASECTOMY 
Vasectomized rams are commonl y used at the beginning of the breeding 
season to hasten and synchronize the onset of estrous cyclicity of ewes. 
Vasectomized rams are also used as teasers to detect estrous ewes during 
the breeding season for artificial insemination, to carry out programs of 
controlled mating, and to evaluate the pregnancy rate by detecting estrous 
ewes after artificial insemination or after the breeding ram has been 
removed from the flock . 
To my knowledge, there are no reported studies that have critically 
evaluated the time required from vasectomy to the obtainment of azoospermic 
ejaculates in rams. Spermatozoa have been found in ram ejaculates for as 
long as 430 days after vasectomy (62). The long and uncertain time lag 
required after vasectomy for the safe use of vasectomi zed rams as teasers 
is conducive to economic losses for the sheep producer and has legal 
implications for the veterinary practitioner . 
This study was designed to determine: a) the time after vasectomy 
required for the clearance of spermatozoa from the ejaculate, b) whether 
flushing the vasa deferentia at the time of vasectomy shortens the time 
from vasectomy to the obtainment of azoospermic ejaculates, and c) the 
viability of spermatozoa in the ejaculates of vasectomized rams during the 
period of spermatozoal clearance. 
Literature Review 
The time elapsed from vasectomy to azoospermia has not been 
critically determined for the ram. Scattered reports recommend to avoid 
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the use of rams for matings for 14 days after vasectomy (63) and 30 days 
after removal of the caudae epididymides (64). However, nonmotile, 
morphologically normal spermatozoa have been found in ram ejaculates up to 
430 days after vasectomy (62). In addit ion, a c l a im has been made (65) 
that rams should b e ejaculated at l east 3 time s a fter vasectomy to r educe 
the number of spermatozoa in the ejaculate to "the low levels normally 
associated wi th sterility" . 
The time elapsed from vasectomy to azoospermia (25,66,67) is 
influenced by t h e s pecies, variation among animals, and likely by t h e 
frequency of seminal collection after vasectomy . Ejaculates fr om 
vasectomized dogs (67,68), cats (66,68), rams (62,65), llamas (69), and men 
(70-73) , or e j aculates from epididymally ligated rams (7) and bulls (74,75) 
containe d spermatozoa for var i able, but prolonged periods of time after 
bilateral vasectomy or epididymal ligation. Spermatozoa have been observed 
in ejaculates of vasectomized men for up to 1 year after vasectomy (70), 
and in ejaculates of vasectomized rams 430 days after vasectomy (62). 
The site of vasectomy (66-68) seems to influence the r ate of 
clearance of s permatozoa from ejaculates of dogs and cats, because the 
interval from vasectomy to azoospermia appears to shorten (68) as the site 
of severance or occlusion approaches the urethral end of t h e vasa 
deferentia. It has been reported (62) t hat t h e wel l developed ampulla of 
t h e vas deferens of the ram is a ma j or site of storage for spermatozoa 
after vasectomy. However, studies on the time required after vasectomy to 
clear the ejaculates from spermatozoa in dogs (67,68) and cats (66,68) 
indicate that the vasa deferentia are minor sites of storage of 
12 
spermatozoa, whereas the caudae epididymides are the major source of 
ejaculated spermatozoa. 
The number of spermatozoa released from the vas deferens after 
vasectomy is likely influenced by the spermatozoal load in the vas deferens 
at the time of vasectomy. In sexually rested rabbits, there was a 
decreasing gradient in the spermatozoal content of the vas deferens toward 
the distal, urethral end of the vas (35). Sexual stimulation without 
ejaculation increased the number of spermatozoa in the vas deferens, 
particularly in the abdominal portion of the vas (35). However, 
immediately after ejaculation , the vas deferens of the rabbit contained 
fewer spermatozoa than during sexual rest or sexual stimulation, and the 
number of spermatozoa of the abdominal portion of the vas was similar to 
that of the scrotal portion (35) . 
Motile spermatozoa were found in human ejaculates up to the 15th day 
post-vasectomy in a study (71) in which the frequency of ejaculation was at 
least 1 ejaculation every 8 days. Spermatozoa capable of fertilization, as 
assessed by the zona-free hamster egg test, were recove red in human 
ejaculates as long as 12 days after vasectomy (76). Motility of ram 
spermatozoa, estimated by the swirling of spermatozoa in whole samples of 
ejaculates, declined to zero by the third post-vasectomy ejaculate, 
independently of whether it was co llected from 7 hours to 6 days after 
vasectomy (65) . Spermatozoa obtained from the cauda epididymis and vas 
deferens of rams 60 days after ligation of the corpus-cauda epididymal 
junction were found to be motile (7). 
Flushing the vasa deferentia at the time of vasectomy reduced to zero 
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the number of intact spermatozoa in the ejaculate by postvasectomy day 6 in 
the dog (25) and by postvasectomy day 7 in the cat (25), whereas the 
vasectomized, but non-flushed controls still had intact spermatozoa in 
their ejaculates by day 14 and detached spermatozoal heads by day 35 in the 
dog, and intact spermatozoa by day 28 and detached spermatozoal heads by 
day 63 in the cat. In view of these results (25), it is possible that the 
time elapsed from vasectomy to azoospermia could be shortened in the ram by 
flushing the vasa deferentia at the time of vasectomy. Spermatozoa were 
found in smears of centrifuged samples of human ejaculates 15 weeks after 
flushing the vasa deferentia at the time of vasectomy (77). These results 
(25,77) suggest that anatomical differences among species might influence 
the time of clearance of spermatozoa from the ejaculates because, unlike 
the vasa deferentia of dogs and cats, the vasa of men and rams have well 
developed ampullae. 
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MATERIALS AND METHODS 
PART I 
Experiment 1. Effect of Xylazine on the Retrograde Flow of 
Spermatozoa into the Urinar y Bladder of 
Rams during Electroejaculation 
Twelve adult rams, including nine western range and three polypay 
(average body weight ± SD - 90 ± 17 kg) were used to determine whether 
xylazine: a) affects the electroejaculatory response, and b) induces 
retrograde flow of spermatozoa into the bladder of sexually rested rams . 
Rams were quarantined for four weeks, sheared, and treated for external and 
internal parasites. Rams were fed a lfalfa hay supplemented with a mixture 
of crushed grains. Rams were r andoml y assigned in a 3 x 4 factorial 
design, with rams nested within weeks, to three groups of four rams each, 
as shown in Table 1 : Group 1, electroejaculation; Group 2, treatment with 
xylazine followed by electroejaculation; and Group 3, treatment with 
xylazine alone. Treatments were replicated four times, once each week. 
Table 1. Experimenta l design (Expe riment 1) 
Week 
1 
2 
3 
4 
Electroejaculation 
4 Rams 
Treatment groups 
Xylazine plu s 
e l ectroe jacu l ation 
4 Rams 
Xylazine 
4 Rams 
15 
The following end points were determined for the electroejaculates 
obtained from rams of Group 1 and 2: volume (ml), spermatozoal 
concentration (106/ml), and total number of spermatozoa (106 ) . The end 
points determined for the urine obtained from rams of t he three treatment 
groups during the first post-treatment micturition were: volume (ml), 
spermatozoal concentration ( 106/ ml), total number of spermatozoa ( 106 ), 
percentage of viable spermatozoa, and number of urine samples containing 
motile spermatozoa. 
Semen was collected from each ram of Groups 1 and 2 using an 
electrojaculator developed in our l aboratory (78). The electroejaculator 
has an adjustable signal generator to control and monitor the slope, 
voltage, and duration of each electrical stimulus, and the interval between 
stimuli. The protocol for electroejaculation (22) was as follows : a 
commercially available rectal probe (Standard Precision Electronics Inc, 
Denver, Colo.) was used to apply electrical stimuli to t he rams . Rams were 
confined in a crate and remained standing during seminal collection. 
Ejaculation was induced by giving each ram a set of five s eries of 10 
electrical stimuli each, with a sinusoidal wave form at 30 Hz. The first 
series of stimuli was given at 2 V (46 to 90 mA), the second series at 3 V 
(50 to 130 mA), the third series at 4 V (50 to 170 mA), the fourth series 
at 5 V (60 to 190 mA), and the fifth series at 6 V (60 to 200 mA). For the 
50 electrical stimuli, the interval between the onset of consecutive 
electrical stimuli was 10 seconds, t h e slope of stimulus application was 
1 .5 seconds, and the duration of each stimulus, from 0 V to the selected 
peak voltage and back to 0 V was 5 seconds. The seminal fluid and 
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spermatozoa obtained with the 50 electrical stimuli was considered an 
electroejaculate. The volume of electroejaculate was measured in graduated 
tubes and the concentration of spermatozoa was determined by hemacytometric 
counts . The total number of spermatozoa for each electroejaculate was 
estimated by multiplying the volume by the concentration. 
Urine was collected once a week from each ram during micturition. To 
facilitate urine collection, micturition was induced in each ram of Groups 
1, 2, and 3 by an intramuscular (IM) injection of a diuretic (250 mg of 
furosemide). Rams of Group 1 were given furosemide immediately after EE. 
Rams of Group 2 received an IM injection of a solution of 20 mg/ ml of 
xylazine at a dose of 0.4 mg/kg of body weight and EE was initiated 15 
minutes after xylazine injection. Furosemide was given to rams of Group 2 
immediately after EE, approximately 23 minutes after xylazine injection. 
Rams of Group 3 were not electroejaculated and received an IM injection of 
xylazine at the same dosage used for the rams of Group 2 . To equate time 
of treatment between groups, furosemide was given 23 minutes after 
injection of xylazine to rams of Group 3 . 
On the basis of previous observations, it was anticipated that some 
rams would become recumbent after injection of xylazine. Tolazoline, an 
o 2 -adrenergic antagonist, was given intravenously at the dose of 1 mg/kg of 
body weight to prevent or reverse xylazine-induced recumbency in order to 
facilitate the collection of semen and/or urine from rams of Groups 2 and 
3. However, to equate treatments among groups, each ram of Group 1 also 
received an intravenous injection of tolazoline . The injection of 
tolazo line was given approximately 1 minute after the injection of 
17 
furosemide for rams of Groups 1, 2, and 3, excep t for 3 of the 4 r a ms of 
Group 2 that b ecame recumbent before or during EE in 12 of the 1 6 seminal 
collect ions . In t h ose cases, tolazoline was given at the t ime of 
recumbency, so that EE could be performed while rams were standing in the 
c rate, and furos e mide was then given immediately after EE . Time of 
injection of drugs and react ion of rams we re recorded. 
The post-treatment urine, which consisted of the urine vo ided during 
the first micturi t ion after furosemide injection, was collecte d in plastic, 
600 ml cups placed in a woode n s upport held under the prepuce, while the 
r am was urinating. The time elapsed from furosemide injection to 
micturition was recorded. Immediately after micturition, the post-
treatment urine was mixed and a samp le was taken a nd immediately examined 
f or motile spermatozoa. The sample was placed on a microscope slide, 
previously warme d to 37 °C on a s lide warmer , and t he preparation was 
observed at a magnification of 400X . Spermatozoa displaying independent 
movement were conside red motile. Th e time elapsed from urine collect i o n to 
ev a luation of spermatozoal motility was recorded . 
Immediately after the examination for spermatozoa l motility, a n eos in 
B dye-exclusion assay for spermatozoal viability ( 79) was done for a sample 
of the post -treatment urine obtained from each ram. The sampl e was placed 
in a chamber made as follows: a 25 x 75 mm microscope sl ide was warmed to 
37 °C on a slide warmer and an area of a pproximate l y 18 x 18 mm was ringed 
on the slide with liquid petrolatum . The petrolatum was applied through a 
23-gauge nee dle attached to a syringe loaded with petrolatum. To 
facilitate the discharge of petrolatum, t he n eedle was warmed briefly in a 
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flame. The protocol for the spermatozoal viability assay was as follows : 
10 µl of urine were placed inside the ringed area of a warm slide (37 °C). 
The urine sample was then gently mixed with 10 µl of a warm (37 °C) 
buffered saline solution containing 0.15 % of eos in B, HEPES (0.015 M), 
NaCl (0. 134 M), and KCl (0 . 005 M). The pH of this saline s o lution was 
prev iously adjusted to 7.4 with lN NaOH before adding the eosin B . After 
mixing the eosin B buffered solution with the urine , the ringed area on the 
microscope slip was sealed with a 22 x 22 mm coverslip to prevent 
evaporation of the sample. The preparation was then incubated in the dar k 
at room temperature ( 18 to 24 °C) for 1 5 minu tes. To determine 
spermatozoal viability, the preparation was the n examined at 400X with a 
light mic roscope , using oblique illumination and a didymium filter . The 
number of stained and unstained spermatozoa were counted for each 
preparation . Whens 200 cells were present, all the spermatozoa in the 
pre paration we r e evaluated. The counting period lasted for up to 5 minutes 
after the incubation period . The percentage of u nstaine d spermatozoa in 
the preparation was recorded and considered to represent the percentage of 
spermatozoal viability for t h e sampl e . To evaluate spermatozoal viability 
and spermatozoal motility within the viab ili ty preparatio n , motile and 
nonmotile spermatozoa which remained unstained during exposure to eosin B 
were considered viable . The number of samples containing spermatozoa 
display ing independent , either progr essive or stationar y, movement was 
determined . 
The volume of urine collected during the first mi c turition after 
furo semide injection was measured in graduated cylinders. The 
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concentration of spermatozoa in urine was determined by placing a sample of 
undiluted urine in each of the two chambers of a hemacytometer and 
examining the preparation at 400X. If spermatozoa were not found in any of 
the 25 large squares of each chamber , the urine was considered to be 
azoospermic. The total number of spermatozoa in urine was estimated by 
multiplying the volume of urine collected by the concentration of 
spermatozoa in the urine. To determine the percentage of retrograde flow 
for rams of Groups 1 and 2, the number of spermatozoa displaced from 
storage sites in the epididymides and vasa deferentia was estimated by 
adding the total number of spermatozoa in the electroejaculate to the total 
number of spermatozoa in the urine. The percentage of retrograde flow was 
then calculated by dividing the total number of spermatozoa in the urine by 
the number of spermatozoa displaced. 
Statistical analysis 
Analysis of variance (ANOVA; 80,81 ) was used to determine the effect 
of treatment, week , and the interaction between treatment and week on the 
volume, spermatozoal concentration , and total number of spermatozoa in the 
electroejaculates; on the percentage of retrograde flow; and on the urine 
volume, spermatozoal concentration, total number of spermatozoa, and 
percentage of viable spermatozoa in the urine. For the ANOVA on percentage 
of retrograde flow and percentage of spermatozoal viability, percentages 
were transformed to the arcsin of the square root of 1/ 100 of the 
percentages. The sources of variation were: treatment, week, and 
interaction treatment x week . Ram within treatment was used as the error 
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term for treatment effect, and the general error was used as the error term 
for week effect and interaction treatment x week. Significance was 
established at P~0 .05. The conservative F value (82) was used to confirm 
significance for the effect of week and for the interaction treatment x 
week. x2 analysis (80) was used to determine the effect of treatment on 
the ratio: number of urine samples that had motile spermatozoa in samples 
of urine that had spermatozoa . 
Experiment 2. Effect of Xylazine on the Retrograde Flow of 
Spermatozoa into the Urinary Bladder 
of Sexually Rested Rams 
The results of Experiment 1 docume nted retrograde flow of spermatozoa 
into the bladder of rams after treatment with xylazine in the absence of 
ejaculation. Because of the experimental design and adjustments made in 
Experiment 1, a potentiating or interactive effect of tolazoline could not 
be ruled out. Thus, it became important to determine whether or not 
xylazine induces retrograde flow of spermatozoa into the bladder of 
sexually rested rams and gain information regarding ram variation in the 
retrograde flow of spermatozoa into the bladder in response to xylazine. 
The twelve r ams used in Experiment 1 were used again in Experiment 2, 
after a period of at least 14 days of rest between experiments . Rams were 
maintained as described in Experiment 1. Body weight was not determined 
for these rams at the beginning of the experiment. Rams were randomly 
assigned in a 2 x 3 split plot factorial design, with rams nested within 
weeks, to two treatment groups of 6 r ams each: Group 1, control saline 
solution; Group 2, treatment with xylazine. The two treatments were 
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replicated three times, once each week. The major fac tors of the 
experimental design were two treatments and three weeks, with two subplots 
(pre- and post-treatment urine), as shown in Table 2 . 
The following end points were determined in the pre- and post-
treatment urine: volwne (ml), spermatozoal concentration (106/ ml), total 
nwnber of spermatozoa (10 6 ) , perce ntage of viable spe rmatozoa , and nwnber 
of urine samples containing motile spermatozoa. The time elapsed from 
treatment to the first post-treatment micturition was recorded. The nwnber 
of post-treatment micturitions was determined as a complementary end point . 
Pre- and post-treatment urine was collected from each ram, once a 
week for three weeks. To collect urine, all r a ms we r e placed in a home-
made harness before injection of xylazine or saline to support the 
xylazine-treated rams as they became recwnbent. A hole in the harness 
allowed the collection of urine from the preputial opening while the rams 
Table 2. Experimental design (Expe riment 2) 
Treatment groups 
Week Urine sample Saline Xylazine 
1 Pre 6 Rams 6 Rams 
Post 
2 Pre 
Post 
3 Pre 
Post 
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were urinating. To facilit a te the collection of urine, micturition was 
induced by treatment with furosemide . Each ram was given an IM injection 
of 250 mg of furosemide and the time of injection of furosemide was 
recorded. The pre-treatment urine consisted of the urine obtained from the 
first micturition after furosemide injection . The pre-treatment urine was 
collected in a 1200 ml plastic cup held in close apposition to the prepuce 
by elastic straps . These straps allowed for the placement or removal of 
the cup without disturbing the ram. The time of the pre-treatment 
micturition was recorded. Immediate l y after the pre-treatment micturition, 
control rams (Group 1 ) received an IM injection of 2 ml of 0.9 % 
physiologic saline solution, and treated rams (Group 2) were given an IM 
injection of a solution of 20 mg/ ml x y lazine, at a dose of 0 . 4 mg/ kg of 
body weight . The time of injection of xylaz ine or the saline solution was 
recorded. 
The first post-treatment mictur ition was defined as the earliest 
micturition occurring beyond 6 minutes after xylazine or saline injection, 
because the estimated half life of distribution of xylazine after IM 
injection in sheep was reported (83) to be 5 . 45 minutes. Time e lapsed from 
treatment with saline or xylazine inject i on to the first post-treatment 
micturition was recorded . The post-treatment urine was collected in a 4 
liter plastic container connected to a plastic funnel by a 1 m long, 
flexible plastic tube. The funnel was held in close apposition to the 
prepuce by elastic straps. In addition, and to satisfy the purposes of 
this experiment, the post - treatment urine consisted of all the urine voided 
during the micturition or micturit ions that occurred within 60 minutes 
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after xylazine or saline injection, regardless the number of micturitions 
that occurred during that post-treatment period. 
Immediately after the pre- and post -treatment urine were collected, 
viability of spermatozoa was determined in the pre- and post-treatment 
urine, respectively, using the eosin B dye-exclusion assay (79) as 
described for Experiment 1 . However, because in Experiment 1 it was found 
that dead spermatozoa stained within the first 5 minutes of the 15 minute 
incubation time that was allowed, the incubation period was shortened to 5 
minutes for Expe riment 2, to minimize the potential toxic effects of 
exposure of ram spermatozoa to urine and eosin B. Thus, a complementary 
evaluation of motility for spermatozoa in urine without using any staining, 
as it was done for Experiment 1 , was cons idered to be unnecessary. A 
filter system consisting of 1 or 2 cyan filters, instead of t he didymium 
filter used for Experiment 1, was placed over the light source of the 
microscope to increase the color contrast of the preparation. The degree 
of color saturation of the cyan blue filter system was adjusted for each 
preparation by placing either 1 or 2 filters, such that the red background 
produced by eosin B was neutralized to clearly differentiate stained or 
unstained spermatozoa. The number of urine samples containing spermatozoa 
displaying independent, either progressive or stationary, movement was 
determined as des cribed for Experiment 1. The volume, spermatozoal 
concentration, and total number of spermatozoa in the pre- and post-
treatment urine were determined as for Experiment 1. 
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Statistical analysis 
ANOVA (80 , 81) was used to determine the effect of treatment, week, 
and the interaction between treatment and week on the volume of pre- and 
post-treatment urine, and on the spermatozoal concentration, total number 
of spermatozoa, and percentage of viable spermatozoa in the pre- and post-
treatment urine. ANOVA was also used to determine the effect of treatment, 
week, and interaction between treatment and week on the time elapsed from 
treatment to the first post-treatment mic turition, and on the number of 
post - treatment micturitions . For the ANOVA on percentage of spermatozoal 
viability , percentages were transformed to the arcsin of the square root of 
1/ 100 of the percentages. The sources of variation were : treatment, week , 
and interaction treatment x week. Ram within treatment was used as the 
error term for treatment effect, and the general error was used as the 
error term for the effect of week and inte raction treatment x week. 
Significance was established at P~0.05 . The conservative F value (82) was 
used to confirm significance for the effect of week and for the interaction 
treatment x week. x2 analysis ( 80 ) was used to determine the effect of 
treatment on the ratio: number of urine s amples that had motile spermatozoa 
in samples of urine that had spermatozoa . 
Experiment 3. Effect of Xylazine on the Retrograde Flow of 
Spermatozoa into the Urinary Bladder of 
Sexually Rested, Catheterized Rams 
The possibility of interactions among drugs (xylazine, tolazoline, 
and furosemide) affecting the response of rams to treatment in Experiments 
1 and 2 of this study, and the de layed a nd possibly incomplete micturitions 
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of rams which were treated with xy lazine in Experiment 2, prompted the 
design of another experiment to test for an effect of xylazine on 
retrograde flow of spermatozoa into the bladder without using any other 
drug that could interact with xylazine. To facilitate urine collection, 
this experiment was done in rams which had a permanent catheter surgically 
implanted in the urinary bladder . 
Eight adult rams, including five western range and three polypay, 
were used in this study , which was initiated 10 months after Experiment 2 
was completed. Seven of these rams were from Experiment 2, and another ram 
was purchased for the present experiment. Rams were housed in individual 
pens and fed as described in Experiment 1 . The average body weight (±SD) 
at the start of Experiment 3 was 96 ± 17 kg . 
A catheter was surgically implanted (22) into the urinary bladder of 
each ram. Before surgery, rams were given an IM injection of xylazine (0.4 
mg/ kg of body weight) and then were anesthetized with sodium pentobarbital 
(7 . 5 mg/kg of body weight, IV) , 10 minutes after administration of 
xylazine . An indwelling catheter was placed in the jugular vein and used 
to administer maintenance doses of sodium pentobarbital , as needed during 
surgery. Xylazine (0.2 mg/kg of b ody weight, IM) was given hourly during 
surgery. The jugular catheter was also used to infuse a 0.9 % saline 
solution containing 24 mEq of sodium bicarbonate/l (5 ml /kg of body 
weight/h) during surgery (22). The midventral and surrounding skin areas 
were clipped free of wool, washed, disinfected , and draped . A longitudinal 
incision (10 to 15 cm long) extending cranially from the base of the 
scrotum was made through the abdominal wall . The incision was parallel to 
26 
the penile sheath and approximately 3 to 4 cm lateral from it . A Tygon ( S-
50 HL tubing, Norton Co , Plastics and Synt he ti cs Divi sion , Akron , OH ) tube 
(2.38 mm ID, 3.97 mm OD , and 120 cm long) was used to ca t heterize the 
urinary bladder. The proximal (bladder) end of the catheter had a Dacron 
pad (Troy Mills Inc, Troy, NH 03465) glued (Silastic Medical Adhesive , Dow 
Corning Corp, Midland, MI) to the outside of the catheter to suture and 
secure the catheter to the bladder . The urinary bladder was exteriorized, 
the catheter was then inserted through a hole made wi t h a sharp probe in 
the centrum verticis of the bladder, and the catheter was then anchored to 
the bladder with sutures. The proximal end of the catheter extended 
approximately 4 cm into the bladder and had approximately 10 additional 
oval openings to facilitate urine withdrawal . The distal end of the 
catheter was passed through the abdominal wall, directed under the skin 
with the aid of a metal tube, and then exteriorized in the right lumbar , 
paravertebral area as previously described (22) . The exteriorized catheter 
was plugged and maintained in a cloth pouch sutured to the skin. After the 
abdominal incision was closed, rams were returned to their pens and given 
1 mg of tolazoline/kg of body weight, IV to hasten recovery from anesthesia 
(22 ). Each ram was allowed at least 7 days to recover from surgery. 
During the first day of this period of recovery, the catheter was allowed 
to drain continuously . The distal end of the catheter was plugged on the 
second day of recovery, and the catheter was then monitored periodically 
for patency for the duration of the study . After each urine withdrawal, 
the catheter was filled with approximately 4 . 0 ml of a 0. 02 % solution of 
nitrofurazone, plugged, and replaced in the pouch. 
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After recovery from surgery , rams were rando mly as s igned , in a 2 x 5 
split plot factorial design with rams nested within pe riods of collection , 
to two treatment groups of 4 rams each : Group 1 , c ontro l s aline solution; 
Gr oup 2, treatment with xylazine. The two tre atments we r e replic ated five 
times over a period of fifteen days, once every t hree or four days, 
alternatively , as shown in Table 3. The major factors were two treatments 
and five periods of col l ection, with two subplots: pre - and post-treatment 
urine. The pre-treatment urine consisted of a singl e sample, and the post-
treatment urine consisted of three s e quential samples, which were collected 
Table 3. Experimental design ( Experiment 3) 
Treatment groups 
Period of Urine 
collection sample Minutes Saline Xylazine 
1st Pre 4 rams 4 rams 
(day 1) Post 20 
40 
60 
2nd Pre 
( day 4) Post 20 
40 
60 
3rd Pre 
(day 8) Post 20 
40 
60 
4th Pre 
(day 11) Post 20 
40 
60 
5th Pre 
(day 15) Post 20 
40 
60 
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at 20, 40, and 60 minutes after treatment with saline or xylazine, as shown 
in Table 3. 
For each ram and day of collection, the following end points were 
determined in the pre-treatment sample and in each of the three post-
treatment samples of urine obtained from the bladder: volume (ml ), 
spermatozoal concentration ( 106/ ml), total number of spermatozoa (106 ), and 
number of urine samples containing motile spermatozoa. 
To enhance the withdrawal of measurable vo lumes of fluid from the 
bladder at each urine collection, 60 ml of physiologic saline solution were 
infused into the bladder through the catheter immediately before withdrawal 
of each pre- or post-treatment sample of urine . At each collection day, 
the pre-treatment urine was collected from the catheter by evacuating the 
bladder. Immediately after collection of the pre-treatment urine, control 
rams (Group 1) received an IM injection of 2 ml of 0.9 % physiologic saline 
solution, and treated rams (Group 2) were g i ven an IM injection of a 
solution of 20 mg/ml xylazine, at a dose of 0.4 mg/kg of body weight. The 
time of injection was recorded . To allow for maximal effects of xylazine 
(83), post-treatment urine was obtained from control and treated rams by 
evacuating the bladder at 20, 40, and 60 minutes after saline or xylazine 
injection. 
Urine was examined at 400X for motile spermatozoa immediately after 
the pre- and each of the post-treatment samples of urine was collected. 
The number of urine samples containing motile spermatozoa was determined as 
described for Experiment 1. The eosin B assay for viability of spermatozoa 
was not done in this experiment. For each ram and day of collection, the 
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volume of urine, spermatozoal concentration, and total number of 
spermatozoa in the pre-treatment urine and in each of the post-treatment 
samples of urine, obtained at 20, 40, and 60 minutes after treatment, were 
determined as described for Experiment 1. For each ram and day of 
co llection, the overall volume of post-treatment urine was estimated by 
adding the volume of urine obtained f or each of the post-treatment samples, 
and the overall total number of spermatozoa in the post-treatment urine was 
estimated by adding the total number of spermatozoa in the urine obtained 
for each of the post-treatment samples. For each ram and day of 
collection, the overall concentration of spermatozoa in the post-treatment 
urine was then estimated by dividing the overall total number of 
spermatozoa in the post-treatment urine by the overall volume of post-
treatment urine. 
Rams were observed for masturbation on each day of collection . Onl y 
on one occasion, a ram (Group 2) was observed masturbating shortly before 
the planned beginning of urine co llection . For this ram, the urinary 
bladder was flushed with saline through the catheter to induce micturition. 
The treatment and collection of urine samples were delayed for 40 minutes. 
The pre-treatment urine for this ram was azoospermic. All data from this 
ram were included in the statistical analyses and in Tables. 
Statistical analysis 
ANOVA (80,81) was used to determine the effect of treatment, day of 
collection, and the interaction between treatment and day of collection on 
the volume of urine, spermatozoal concentration, and total number of 
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spermatozoa in the pre- and post-treatment urine. The sources of variation 
were: treatment, day of collection, and interaction treatment x day of 
collection. Ram within treatment was used as the error term for treatment 
effect, and the general error was used as the error term for day of 
collection and the interaction treatment x day of collection. Significance 
was established at P~0.05. The conservative F value (82) was used to 
confirm significance for the effect of day of collection and for the 
interaction treatment x day of collection . 
ANOVA was also used to determine the effect of time of sampling (20, 
40, or 60 minutes after treatment) and the interaction treatment x time of 
sampling on the volume of urine, spermatozoal concentration, and total 
number of spermatozoa in the sequential samples of post-treatment urine. 
The general error was used as the error term for time of sampling and 
treatment x time of sampling. The conservative F value was also used to 
confirm significance for the effect of time of sampling and for the 
interaction treatment x time of sampling. Tukey's w test (80,8 1) was used 
to test for differences between means of treatment groups or differences in 
means within treatment groups for volume, spermatozoal concentration , and 
total number of spermatozoa of the sequential samples of post-treatment 
urine when ANOVA indicated a significant F ratio for treatment or for time 
of sampling. Regression lines (80,81) were calculated to characterize the 
rate of change of the end points determined in the sequential samples of 
post-treatment urine for which ANOVA indica ted a significant F ratio for 
time of sampling. 
x2 analysis (80) was used to determine the effect of treatment on the 
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ratio: number of urine samples that had motile spermatozoa in samples of 
urine that had spermatozoa. 
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PART II 
Experiment 4. Clearance of Sperma t ozoa from Electroejaculates of 
Vasectomized Rams after Flushing the Vasa 
Deferentia at the Time of Vasectomy 
Ten adult rams, including seven western range and three polypay, were 
used in this study to determine the time after vasectomy required for 
clearance of spermatozoa from the ejaculate and to determine whether 
flushing the vasa deferentia at the time of vasectomy shortens the time 
elapsed from vasectomy to azoospermia . Nine of these rams were previously 
used in Experiment 1 and also in Experiment 2, and 7 of these rams were 
used again in Experiment 3, including the ram purchased for Experiment 3. 
Experiment 4 was initiated 14 days after Exp e riment 3 was completed. Rams 
were maintained as described in Experiment 1. The average (± SD) body 
weight at the start of Experiment 4 was 101 ± 17 kg. Rams were randomly 
assigned in a 2 x 11 days of collection factorial design, with rams neste d 
within periods of collection, to two groups of five rams each , a s shown in 
Table 4: control group, vasectomy; treated group, vasectomy plus flushing 
of the vasa deferentia. Pre-vasectomy electroejaculates were obtained from 
each ram immediately before surgery on day 0 . Post- v asec tomy 
electroejaculates were obtained on post -vasec tomy days 3 and 7 , and then at 
7 day intervals (Table 4) until day 63. 
The following end points were determined in the pre- and post -
vasectomy electroejaculates : volume ( ml ), spermatozoal c oncentration 
(106/ ml), number of intact spermatozoa (106), total number of spermatozoa 
( 106 ), percentage of viable spermatozoa, and number of electroejaculates 
c ontaining motile spermatozoa. 
33 
Table 4, Experimental design (Experiment 4) 
Day of 
collection 
0 
3 
7 
14 
21 
28 
3 5 
42 
49 
56 
63 
Control 
group 
5 Rams 
Treated 
group 
5 Rams 
Vasectomy for treated and control rams was performed as follows: rams 
were anesthetized as described for Experiment 3. The scrotum and 
surrounding areas were then clipped, washed and disinfec ted . Rams were 
positioned in dorsal recumbency and the scrotum was pushed caudally. A 4 
cm incision was made on the midline of the scrotal neck, beginning 
approximately 3 cm distal to the abdominal wall . Each vas deferens was 
approached from this single midline incision, exposed by blunt dissection 
and then fixed with two forceps . For the control rams , each vas deferens 
was isolated, double-ligated with si lk suture, and then severed between the 
ligatures . The scrotal incision was then c losed. For the treated rams , 
each vas deferens was isolated, and then ligated with silk suture, as 
described for the control rams, except that the ligature on the distal, 
abdominal end of the vas deferens was not tied, but placed loosely around 
the vas. The vas deferens was then severed between the ligatures, as 
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described for the control rams . The loosely ligated , distal end of the vas 
deferens was held by the ligature and positioned with forceps, so that the 
opening of the lumen could be visualized. The vas deferens was cannulated 
wi th the blunted end of a 1.0 inch (2.54 cm) long , 22-gauge needle and 
flushed with 25 ml of a 0 . 01 % solution of trypan blue in 0.9 % isotonic 
saline solution (25) . To determine post-vasectomy viability of spermatozoa 
in rams of the treated group, a spermicidal agent was not added to the 
flushing solution . The infusion of the flushing solution was done in a 
pulsating fashion, using 15 ml syringes to help overcoming the resistance 
opposed to flushing. No attempts were made to measure this resistance. As 
it was anticipated (25), most of the flushing solution retrograded into the 
bladder, and only trace amounts of blue flushing solution were seen at the 
preputial opening during or immediately after flushing in two of the five 
treated rams. Immediat ely after flushing , the distal end of each vas 
deferens was ligated . The scrotal incision was sutured once this process 
was completed for both vasa deferentia. 
Pre- and post-vasectomy electroejaculates were collected for each ram 
as described in Experiment 1. Immediately after semen collection, the 
electroejaculates were examined at 400X for motile spermatozoa . Viability 
of spermatozoa in the electroejaculates was eva l uated using the eosin B 
dye-exclusion assay (79), as described in Experiment 1 with the 
modifications introduced in Experiment 2 for the estimation of spermatozoal 
viability in urine. A 1/ 10 or 1/ 100 semen dilution was made, as needed, by 
diluting a sample of electroejaculate in the buffered saline solution 
described in Experiment 1. Depending on the spermatozoal concentration of 
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the electroejaculate, 10 µl of a diluted ( 1 / 10 or 1 / 100) o r undiluted 
seminal sampl e were placed inside the ringed area of t he chamber and were 
t h en gently mixed with 10 µl of 0.15 % eosin B solution. The incubation 
period was 5 minutes b efore evaluation. Spermatozoal viability and 
motility within the viability preparation we re determined as desc ribe d in 
Exp e riment 2. The volume, con cen tration of spermatozoa, and t otal number 
o f spermatozoa were es timated for each electroejaculate i n diluted or 
undiluted samples as described in Experiment 1. Electroej aculates were 
conside r e d to be azoospermic when s permatozoa were not found in duplic ate 
undiluted samples of post-vasectomy e l ectroejaculates. 
Statistical analysis 
ANOVA (80,81) was used to determine the effect of treatmen t, day of 
collection , and the inte ract i on between treatment and day of collection on 
the vo lume of the electroejaculates , and on t h e spe rmatozoal concentration, 
number of intact spermatozoa, total numbe r of spermatozoa, and percentage 
of viab l e spermatozoa in the electroejaculates. For the ANOVA o n 
percentage of s perma tozoa l viability, p ercentages were t r ansformed to t h e 
arcsin of t h e square root of 1 / 100 of the percentages. ANOVA was also used 
to determine t h e effec t of treatme nt on the cumulative tota l number of 
s permatozoa r e l eased to t h e post-vasectomy electroejaculates. The sources 
of var i ation we r e: treatment, day of collect ion , a nd interac tion treatment 
x day of collection . Ram within treatment was used as the error term for 
treatment effect , and the general e rror was used as the error term fo r day 
o f collection and interaction treatment x day o f co l lection. Significance 
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was established at P~0 .05. The conservative F value (82) was used to 
confirm significance for the e ffect of day of collection and for the 
interaction treatment x day of co llec tion . 
ANOVA ( 80,81 ) was also used to test for post-vasectomy differences in 
the rate of change between treatment groups in the number of intact 
spermatozoa, total number of spermatozoa, and cumulative total number of 
spermatozoa in the electroejaculates . 
Regression lines ( 80,81 ) were calculated for each treatment group to 
characterize the rate of change between PVD and the number of intact 
spermatozoa , total number of spermatozoa, and cumulative total number of 
spermatozoa in the post-vasectomy e l ectroe jaculates . Data on total number 
of spermatozoa and number of intact sperma tozoa were transformed to natural 
logarithm , using the expression (25 ) ln [(variable (10 6 ) + 0 . 0001) x (1 x 
106 ) l . 
x2 analysis (80) was used to determine the effect of treatment on the 
ratio : number of electroejaculates that had motile spermatozoa in 
electroejaculates that had spermatozoa . 
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RESULTS 
PART I 
Experiment 1 
The volume of electroejaculates, collected from rams of Groups 1 and 
2, was not affected (P>O.l, Table 5) by treatment or week, and the 
interaction treatment x week was also not significant (P>O.l). The 
spermatozoal concentration in the electroejaculates was affected (P-0.015, 
Table 5) by treatment , but was not affected ( P>O. l) by week , and the 
interaction treatment x week was also not significant (P>O.l). The total 
Table 5. Volume of electroejaculates and concentration and total number of 
spermatozoa in the electroejacul ates of rams (Experiment 1 ) 
Treatment 
group 
Elec troej acula-
tion (Group 1) 
Xylazine + 
electroejacula-
t ion (Group 2) 
Source 
Treatment 
Wee k 
Week x trt 
1 
3 
3 
Volume 
( ml) 
5.0 ± 2.5 
4.0 ± 1.6 
>0.1 
>0.1 
>0.1 
Electroe j aculate 
Spermatozoal concen -
tration (106 /ml) 
1458 ± 535 
848 ± 407 
p 
-0.015 
>0.1 
>0.1 
Total No. of 
spermatozoa (106 ) 
7387 ± 4695 
3321 ± 1835 
>0 . 1 
>0.1 
>0. 1 
df - degrees of freedom ; P - probability; trt - treatment . Data 
presented as overall mean± SD; values over time and across rams , N - 16 
observations for each treatment group. 
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number of spermatozoa in the elec troejaculates was not affected ( P>O.l , 
Table 5) by treatment or week , and the interaction treatment x week was 
also not significant (P>O.l) . 
The volume of urine collected from rams of Groups 1, 2, and 3 during 
the first post-treatment micturition was not affected (P>O.l, Table 6) by 
Table 6. Volume of urine, concentration and total number of spermatozoa 
in the urine collected during the first post-treatment 
micturition, and percentage of retrograde flow of spermatozoa 
into the urinary bladder of rams ( Experiment 1) 
Urine 
Spermatozoal Total no. of Retrograde 
Treatment Volume concentration spermatozoa flow 
group (ml) (106 / ml) (106 ) (%) 
Electroejacula- 387 ± 245 1. 90 ± 1. 60 897 ± 1152 12 ± 11 
ti on (Group 1) 
Xylazine + 
Electroejacula- 412 ± 175 3.15 ± 2 . 05 1131 ± 721 29 ± 18 
ti on (Group 2) 
Xylazine 
( Group 3) 204 ± 130 5.94 ± 11.47 567 ± 887 NA 
Source df _P_ df _ P_ df _P_ df p 
Treatment 2 >0.1 2 >0 . 1 2 >0 . 1 1 -0.017 
Week 3 >0.1 3 >0.1 3 >0 . 1 3 >0.1 
Week x trt 6 >0.1 6 >0.1 6 >0.1 3 >0 . 1 
NA - not applicable, semen was not collected from rams of Group 3. 
df - degrees of freedom; P - probability; trt - treatment . Data 
presented as overall mean ± SD; values over time and across rams, N - 16 
observations for each treatment group. For Groups 1 and 2, all urine 
samples contained spermatozoa. For Group 3, only 7 of 16 urine samples 
contained spermatozoa. 
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treatment or week, and the interaction treatment x week was also not 
significant (P>O.l). The concentration and total number of spermatozoa of 
spermatozoa in the urine collected during the first post-treatment 
micturition were not affected (P>O.l, Table 6) by treatment or week, and 
the interaction treatment x week were also not significant (P>O.l). The 
percentage of retrograde flow of spermatozoa into the urinary bladder of 
rams of Groups 1 and 2 was affected (P-0.017, Table 6) by treatment, but 
was not affected (P>O.l) by week, and the interaction treatment x week was 
also not significant (P>O.l). 
The urine obtained during the first post-treatment micturition from 
rams of Group 3 was azoospermic (footnote, Table 7) in 9 of 16 collections. 
One of the 4 rams of Group 3 (data not shown in tables) did not have 
spermatozoa in the urine in any of the four weekly collections, 2 of the 
remaining 3 rams had spermatozoa in the urine on alternate weeks, and 1 ram 
had spermatozoa in the urine in 3 of the 4 weekly collections. 
The percentage of viable spermatozoa in the urine obtained during the 
first post-treatment micturition was not affected (P>O.l, Table 7) by 
treatment or week, and the interaction treatment x week was also not 
significant (P>O.l). For the urine collected during the first post-
treatment micturition, the ratio: number of urine samples that had motile 
spermatozoa in samples of urine that had spermatozoa was not different 
(P>O.l, Table 7) between treatment groups. 
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Table 7. Percentage of v iable spermatozoa in the urine co llected from rams 
during the first post-treatment micturition and ratio of urine 
samples that contained motile spermatozoa (Experiment 1) 
Treatment 
group 
Electroejacula-
tion (Group 1) 
Xylazine + 
Electroejacula-
tion (Group 2) 
Xylazine 
(Group 3) 
Source 
Treatment 
Week 
Week x trt 
Spermatozoal viability 
in urine (X) 
46 ± 24 
45 ± 25 
so ± 18 
df _P_ 
2 >0. 1 
3 >0.1 
6 >0.1 
Spermatozoal motility 
in urine 
16 I 16 
15 / 16 
6 I 7 
df _E_ 
2 >0. 1 
df - degrees of freedom; P - probability; trt - treatment. Data for 
spermatozoal viabi lity is presented as overall mean ± SD ; values over time 
and across rams, N - 16 observations for each treatment group, except for 
rams of Group 3, N - 7, because of 9 azoospermic samples. 
8 X2 analysis for the ratio: number of urine samples that had motile 
spermatozoa from the number of samples that had spermatozoa. 
Experiment 2 
The volume of pre - treatment urine was not different (P>O.l, Table 8) 
between treatment groups, was not affected (P>O.l) by week, and the 
interaction treatment x week was also not significant ( P>O.l) . 
The post -treatment urine consisted of all the urine voided within 60 
minutes after treatment , except for 7 co llections from S rams of Group 2 , 
which did not urinate during the 60 minute period and were maintained under 
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observation until the first post-treatment micturition occurred . For these 
7 collections, however, the vo lume of urine was considered to be zero for 
the statistical analysis or tables for vo lume of post-treatment urine. The 
volume of post-treatment urine was affected (P-0.0001, Table 8) by 
treatment, but was not affected ( P>O.l) by week, and the interaction 
treatment x week was also not significant (P>O. l ) . 
Thirteen micturitions from 9 rams occurred before 6 minutes. These 
micturitions were not included in the analysis. The time elapsed from 
treatment to the first post-treatment micturition was affected (P-0.0001, 
Table 8 . Volume of pre- and post-treatment urine of sexually rested rams 
(Experiment 2) 
Volume of urine (ml} 
Treatment 
group Pre-treatment Post-treatment 
Saline-
controls 356 ± 175 1743 ± 366 
(Group 1) 
Xylazine -
treated 400 ± 198 152 ± 195 
(Group 2) 
Source df p 
Treatment 1 >0 .1 - 0.0001 
Week 2 >0.1 >0. 1 
Week x trt 2 >0. 1 >0. 1 
df - degrees of freedom; P - probability; trt - treatment. Data 
presented as overall mean± SD; values over time and across rams, N - 18 
observations for each treatment group, except for post-treatment urine of 
control rams , N - 17, because a datum was not recorde d. 
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Table 9) by treatment, but was not affected (P>O.l) by week, and the 
interaction treatment x week was also not significant (P>O.l). The number 
of post-treatment micturitions within the period of 60 minutes was affected 
( P-0.0001, Table 9) by treatment, but was not affected (P>O. l ) by week, and 
the interaction treatment x week was also not significant ( P>O.l). 
The spermatozoal concentration ( Table 10) and total number of 
spermatozoa (Tab l e 11) in the pre- and post-treatment urine were not 
Table 9 . Time elapsed from treatment to the first post-treatment 
micturition , and number of micturitions within 60 minutes after 
t r eatment of sexually rested r ams (Experiment 2) 
Treatment 
group 
Saline-
controls 
(Group 1) 
Xylazine-
treated 
(Group 2) 
Source 
Treatment 
Week 
Week x trt 
df 
1 
2 
2 
Time to firsta 
micturition 
(min .) 
13 ± 3 
54 ± 21 
-0.0001 
>0.1 
>0 . 1 
Post-treatment 
p 
No. of 
micturitions 
within 60 min. 
5.4 ± 2.2 
0.9 ± 0.9 
-0.0001 
>0. 1 
>0 . 1 
df - degrees of freedom; P - probability; trt - treatment. Data 
presented as overall mean ± SD; values over time and across rams, N - 18 
observations for each treatment group. 
aonly micturitions that occurred after 6 minutes from saline or 
xylazine injection were included in the analysis. 
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Table 10. Concentration of spermatozoa in pre- and post-treatment urine 
of sexually rested rams (Experiment 2) 
Treatment 
groups 
Saline-
controls 
(G roup 1) 
Xylazine-
treated 
(Group 2) 
Source 
Treatment 
Week 
Week x trt 
1 
2 
2 
Spermatozoal concentration (106 /ml) 
Pre-treatment urine 
0.37 ± 1.42 
0.19 ± 0.58 
>0. 1 
>0 . 1 
>0. 1 
p 
Post-treatment urine 
0.006 ± 0.022 
0.096 ± 0.239 
>0. 1 
>0. 1 
>0.1 
df - degrees of freedom; P - probability; trt - treatment. Data 
presented as overall mean± SD; values over time and across rams , N - 18 
observations for each treatment group. For the post-treatment urine, 16 of 
18 urine samples from rams of Group 1 and 11 of 18 urine samples from r ams 
of Group 2 were azoospermic (x2 , 1 df, P<O .l ). 
different ( P>O. l) between treatment groups and were not affected (P>O.l) by 
week , and the interactions treatment x week were also not significant 
(P>O.l). 
The pre-treatment urine contained spermatozoa in 2 of 18 collections 
from rams of Group 1, and in 5 of 18 collections from rams of Group 2. The 
post-treatment urine contained spermatozoa in 2 of 18 collections from rams 
of Group 1, and in 7 of 18 collections from rams of Group 2 . 
The percentage of viable spermatozoa in the pre-treatment urine was 
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Table 11 . Total number of spermatozoa in pre- and post-treatment urine of 
sexually rested rams ( Experiment 2) 
Treatment 
group 
Sal ine-
controls 
(Group 1) 
Xylazine-
treated 
(G roup 2) 
Source 
Treatment 
Week 
Week x trt 
1 
2 
2 
Total No. of spermatozoa (106 ) 
Pre - treatment urine 
97 ± 369 
39 ± 119 
>0.1 
>0. 1 
>0. 1 
p 
Post-treatment urine 
6 ± 21 
25 ± 68 
>0 . 1 
>0.1 
>0.1 
df - degrees of freedom ; P - probability; trt - treatment . Data 
presented as overall mean± SD; values over t ime and across rams , N - 18 
observat ions for each trea tment group. For the post-treatment urine , 16 of 
18 urine samples from rams of Group 1 and 11 of 18 urine samples from rams 
of Group 2 were azoospermic (x2 , 1 df, P<O. l ) . 
not different (P>O.l, Table 12) between t r eatment groups. Th ere was a 
trend (P-0.087, Table 12) for an effect of treatment on the percentage of 
v iable spermatozoa in t he post-treatment urine, but the percentage of 
v iable spermatozoa in the pos t-treatment ur ine was not a f fected (P>O.l) by 
week. The ratio : number of urine samples that had motile spermatozoa in 
samples of urine that had spermatozoa was no t different (P>O.l, Table 12) 
between treatment groups for either the pre - or post -treatment urine . 
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Table 1 2. Percentage of viable spermatozoa in the pre- and post - treatment 
urine of sexually rested rams and ratio of urine samples that 
contained motile spermatozoa ( Experiment 2 ) 
Spermat ozoal viability ( %) Spermatozoal motility 
Treatment Pre-treatment Post-treatment Pre-treatment Post - t r eatment 
group ur i ne urine u rine urine 
Saline -
controls 17 ± 13 7 ± 12 2 I 2 1 I 2 
(Group 1 ) 
Xy lazine-
treated 1 7 ± 24 28 ± 32 2 I s s I 7 
(Group 2) 
Source df _ P_ df _P __ df _E_ df pa 
Treatment 1 >0 . 1 1 -0 . 087 1 >0. 1 1 >0.1 
Week 2 ND 2 >0.1 
df - degrees of freedom; P - probabi l ity; ND - not determined because 
of the number of azoospermic samp l es. Data for spermat ozoa l viability is 
presented as over a ll mean± SD; values over time and acro ss rams; for the 
pre-treatment urine , n - 2 (Group 1) or n - 5 (G roup 2 ) , and for the post -
treatmen t u r i n e, n - 2 (Group 1 ) or n ~ 7 (Group 2) , bec ause of 16 , 13, 16, 
and 11 azoospermic samples, respectively. 
ax2 analysis for t h e r atio: number of urine samples that had motile 
spermatozoa from the number of sampl es t hat had spermatozoa . 
Experiment 3 
The volume of pre-treatment urine was not different ( P>O .l, Table 13 ) 
between t reatment groups, was not affected (P>O. l) by day of collection, 
and the interaction t reatment x day of col lection was a l so not significant 
( P>O.l). The total volume of post-treatment urine collected during the 6 0 
minute period was affected by treatment (P-0.006 , Table 13), but was not 
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Table 13 . Volume of pre-treatment urine and total vo lume of post- t reatment 
urine obtained from the bladder of sexually rested rams within 
60 minutes after treatment ( Experiment 3) 
Volume of urine (ml) 
Treatment 
group Pre-treatmen t Post- t reatment 
Saline -
controls 128 ± 95 263 ± 72 
(Group 1 ) 
Xylazine-
t reated 70 ± 34 864 ± 347 
(G roup 2) 
Source 
Treatment 
Day 
Day x trt 
df 
1 
4 
4 
>0.1 
>0.1 
>0. 1 
p 
df - degrees of freedom ; P - probability; trt - treatment. 
p resented as overall mean ± SD; val ues over t i me and across rams, 
observations fo r each treatment group. 
affected (P>O.l) by day of collection, and the interaction day of 
-0. 006 
>0.1 
>0 . 1 
Data 
N - 20 
col l ection x treatment was also not s ignificant ( P>O.l) . The vo lume of 
urine obtained 20, 40, and 60 minutes a f te r treatment was affected by 
treatment (P-0 . 006 , Table 14 ) , time of samp ling (P- 0.001), and the 
interaction time x treatment was a l so s ignifican t (P- 0.0001, Table 14). 
For the saline control group, t h e mean volume of post-treatment urine 
collected at 20 minutes was larger (P<0 . 05, Table 14 ) than the mean volume 
o f post-treatment ur i n e collected at 60 minutes, but was not different 
(P>0 .05) from the volume of urine col l ected at 40 minutes. However, the 
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Table 14. Volume of urine obtained from the bladder of sexually rested 
rams at 20, 40, and 60 minute s post-treatment (Experiment 3) 
Volume of 2ost-treatment urine (ml} 
Treatment 
grou2 At 20 min. At 40 min. At 60 min. 
Saline-
controls 98 ± 418 86 ± 24ab 80 ± 18b 
(Group 1) 
Xylazine-
treated 217 ± 12lc 337 ± 153d 310 ± 101 d 
(Group 2) 
Source df p 
Treatment 1 - 0.006 
Time 2 - 0.001 
Time x trt 2 ~0.0001 
df - degrees of freedom; P - probability; Time - 20, 40 , or 60 
minutes ; trt = treatment . Data presented as mean± SD; values over time 
and across rams, N - 20 observations for each treatment group. Means 
within columns or rows which do not have a common superscript letter are 
significantly different, P<0 . 05. 
mean v olume of post-treatment urine collected from the x y lazine - treated 
group was smaller (P<0.05, Table 14) at 20 minutes than the mean volume of 
urine collected at 40 or 60 minutes . For each time period , the mean volume 
of post-treatment urine collected from the xylazine-treated group was 55% 
to 74% larger (P<0.05, Table 14) than the v olume of post-treatment urine 
collected from the saline control group . 
The linear regression predicting the rate of c hange in volume of 
urine (Y) as a function of the time elapsed after treatment (X - 20, 40, or 
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60 minutes), and the fitting of the data to the regression lines were as 
follows: Y (ml ) - 106 - 0.5X for the rams of Group 1 (r-0.24 , N-20, 
P-0.054); and Y (ml) - 195 + 2.3 X for the rams of Group 2 ( r-0.28, N-20, 
P-0.03). 
The concentration of spermatozoa in the pre-treatment and in the 
post-treatment urine and the total number of spermatozoa in the pre-
treatment urine were not different ( P>O. l, Table 15) between treatment 
groups, were not affected (P>O.l) by day of collection, and the 
interactions day of collec t ion x treatment were also not significant 
(P>O. l). However, there was a trend approaching significance ( P-0.083, 
Table 15) for an effect of treatment on the total number of spermatozoa in 
the urine obtained within 60 minutes after treatment. In addition, there 
were more azoospermic urine collections from t he control rams (12 of 20) 
than from the t r eated rams (5 of 20, P<0.05, footnote, Table 15). The 
effect of day and the interaction day x treatment were not significant 
( P>O.l, Table 15). 
According to the level of significance established in Materials and 
Methods, the F ratio for effect of treatment on the total number of 
spermatozoa in the urine obtained within 60 minutes after treatment 
indicated only a trend for an effect of treatment. However, I feel 
justified to claim that this treatment effect is significant on the basis 
that the mean of the total number of spermatozoa in the post-treatment 
urine obtained within 60 minutes after treatment was 460 times higher 
( Table 15) for rams of the treated group than for rams of the control 
group. I attribute the lack of a statistical significance to the variation 
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Table 15. Concentration and total number of spermatozoa in the pre-
treatment urine and in the post-treatment urine obtained from 
the bladder of sexually rested rams within 60 minutes after 
treatment (Experiment 3) 
Treatment 
group 
Saline-
controls 
(Group 1) 
Xylazine-
treated 
(Group 2) 
Source df 
Treatment 1 
Day 4 
Day x trt 4 
Spermatozoa! 
concentration (106 /ml) 
Total No. of 
spermatozoa( 106 ) 
Pre-treatment Post-treatment Pre-treatment Post - treatment 
0.01 ± 0.02 
0.05 ± 0.10 
>0.1 
>0.1 
>0.1 
p 
0.01 ± 0.03 
1.9 ± 4.0 
>0.1 
>0 . 1 
>0.1 
1.6 ± 3 . 8 
4 . 0 ± 7.0 
>0.1 
>0.1 
>0.1 
p 
3.2 ± 7.9 
1471 ± 2210 
-0.083 
>0.1 
>0.1 
df - degrees of freedom; P - probability; trt - treatment. Data 
presented as overall mean± SD; values over time and across rams, N - 20 
observations for each treatment group. For the post-treatment urine 
obtained within 60 minu tes after treatment, 12 of 20 urine collections from 
rams of Group 1 and 5 of 20 urine collections from rams of Group 2 were 
azoospermic (x2 , 1 df, P<0.05) . 
among rams within treatment groups, as evidenced by the magnitude of the SD 
(Table 15). Because the total volume of post-treatment urine obtained 
during the 60 minutes of collection was significantly affected by treatment 
(P-0.006, Table 13) and the total number of spermatozoa in the urine i s a 
function of the volume and spermatozoa! concentration of the urine, ANOVA F 
tests for contrasts of data (80,81) for spermatozoa! concentration and 
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total number of spermatozoa in pre-treatment versus post-treatment urine 
were done after the fact (Table 16) to further evaluate whether or not 
the r e was an effect of treatment. The spermatozoal concentration and total 
number of spermatozoa in the urine obtained from the sal ine control rams 
were not different (P>O. l , Table 16) between the pre-treatment and the 
post-treatment urine collections. Treatment with xylazine, however, 
significantly affected the spermatozoal concentration (P-0.048, Table 16) 
and total number of spermatozoa (P-0.009) in the post-treatment urine. The 
spermatozoal concentration in the post-treatment urine collected at 20, 40, 
and 60 minutes was not affected by treatment or time of sampling (P>O.l, 
Table 17), and the interaction time of sampling x treatment was also not 
significant (P>O.l). The total number of spermatozoa in the post-treatment 
urine co llected at 20, 40, and 60 minutes was not affected (P>O. l , Table 
17) by time of sampling, and the interaction time x treatment was also not 
significant (P>O.l). However there was a trend approaching significance 
(P-0.083, Table 17) for an effect of treatment. This trend was independent 
of time of sampling, as indicated by a nonsignificant (P>O.l, Table 17) 
time x treatment interaction. The variation among rams in response to 
treatment may have precluded the statistical detection of a treatment 
effect because, for all means displayed in Table 17 , t he magnitude of the 
SD exceeded that of the mean. 
The pre-treatment urine from rams of Group 1 contained spermatozoa in 
10 of 20 collections, and in 16 of 20 collections for the pre-treatment 
urine collected from rams of Group 2 ( data not shown in tables, x2 , 1 df , 
P<0.05). The post-treatment urine from rams of Group 1 obtained during the 
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Table 16. Statistical analysis (F contrasts) of data for concentration and 
total number of spermatozoa in the pre-treatment urine and in 
the post-treatment urine obtained from the bladder of sexually 
rested rams within 60 minutes after treatment ( Experiment 3) 
Urine 
Pre-
treatment 
Post-
treatment 
Contrast 
Pre vs. 
post 1 
Spermatozoal 
concentration (10 6 / ml) 
Control rams Treated rams 
0.01 ± 0.02 0.05 ± 0.10 
0 .01 ± 0.03 1.9 ± 4.0 
p 
>0. 1 -0.048 
Total No. of 
spermatozoa(l06 ) 
Control rams Treated rams 
1.6 ± 3.8 4.0 ± 7.0 
3.2 ± 7.9 1471 ± 2210 
p 
>0. 1 -0.009 
df - degrees of freedom; P - probability. Data are from Table 15 and 
are presented as overall mean± SD; values over time and across rams, N 
20 observations for each treatment group. 
60 minute period contained spermatozoa in 8 of 20 collections, and in 15 of 
20 collect ions for the post-treatment urine collected from rams of Group 2 
(data not shown in tables, x2 • 1 df, P<0.05). 
x2 analysis for the ratio: number of samples that had motile 
spermatozoa in samples of pre-treatment urine that had spermatozoa was not 
different ( P>O.l, Table 18) between treatment groups. However , the ratio: 
number of samples that had motile spermatozoa in each of the time periods 
of collection of post-treatment urine that had spermatozoa was greater at 
Table 17. Concentration and total number of spermatozoa in the urine obtained from the bladder of 
sexually rested rams at 20, 40, and 60 minutes post-treatment (Exper iment 3) 
Treatment 
groups 
Saline-
controls 
(Group 1) 
Xylazine-
treated 
(Group 2) 
Source 
Treatment 
Time 
Time x trt 
1 
2 
2 
Post-treatment urine 
Spermatozoal concentration (106/ml) 
At 20 min . 
0.001 ± 0.003 
2.2 ± 5.0 
At 40 min . 
0.01 ± 0.04 
2.5 ± 5.8 
p 
>0. 1 
>0.1 
>0 .1 
At 60 min. 
0.02 ± 0.06 
1.4 ± 2.9 
Total No. of spermatozoa (106 ) 
At 20 min . 
0. 1 ± 0.3 
380 ± 634 
At 40 min. 
1.0 ± 3.9 
673 ± 1143 
p 
-0.083 
>0.1 
>0.1 
At 60 min. 
2.2 ± 5 . 9 
418 ± 820 
df - degrees of freedom; P - probabi lity; Time - 20, 40, or 60 minutes; trt - treatment. Data 
presented as mean± SD; values over time and across r ams, N - 20 observations for each treatment 
group. 
l/1 
N 
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Table 18 . Number of urine samp l es that contained motile spermatozoa in the 
pre - and post-treatmen t urine obtained from t he bladder of 
sexually rested r ams ( Experiment 3) 
Treatment 
group 
Saline-
controls 
(G roup 1) 
Xylazine-
t reated 
(Group 2) 
Treat ment 
effect 
1 
Pre-
treatment 
o I 10 
2 I 16 
>0. 1 
Motility of s permatozoa in urine 
Post-treatment 
At 20 min. At 40 min. At 60 min. Overall 
NA o / 4 o I 7 o I 11 
8 I 14 10 I 13 7 / 14 25 I 41 
pa 
NA <0.01 <0.025 <0 .000 5 
NA - not applicable because of azoospermic samples; df - degrees of 
freedom; P - probability. Data presented as number of urine samples t ha t 
had motile spermatozoa from t he number of samples t ha t h ad sperma t ozoa; 20 
samples were collected for each treatment group per each time period (pre-
treatment a nd 20, 40, and 60 minu tes post-treatment). For the overall 
total of post-treatment urine, N - 60. 
ax2 analysis for t he ratio: number of urine samples that had mo ti l e 
spermatozoa from t he number of urine samples that had spermatozoa. 
40 minutes (P<0.01, Table 18 ) and again at 60 minutes ( P<0.025) for the 
treated than for the control group. The overall rat io : number of post-
treatment s amples of urine that had motile spermatozoa from t he total 
number of post -treatment urine samples that had spermatozoa was greater 
( P<0.0005, Table 18 ) fo r the t r eated group than for t h e control group. In 
addition , for all s amples of post-treatment urine collected from each r am 
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for all time periods, more (data not shown in tables , x2 , 1 df, P<0.0005) 
samples of urine containing s permatozoa were obtained from treated rams (41 
of 60) than from control rams ( 11 of 60). 
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PART II 
Experiment 4 
The pre-vasectomy volume of electroejaculates and the spermatozoal 
concentration, total number of spermatozoa, and total numbe r of intact 
spermatozoa on day 0 were not different (P>O.l, Tables 19 through 21) 
between treatment groups. Because one ram, which was not used in 
Experiment 1, consistently voided small amounts of urine during seminal 
collection, data on volume and spermatozoal concentration of the 
electroejaculates of this ram were not included in the statistical analyses 
for these end points. The volumes (Table 19), spermatozoal concentrations 
(Table 20), total numbers of spermatozoa (Table 21) , and total numbers of 
intact spermatozoa (Table 21 ) in the post-vasectomy ejaculates collected up 
to day 63 were not affected (P>O.l) by treatment or day of collection, and 
the interactions day x treatment were also not significant (P>O.l), when 
data were statistically analyzed by the factorial ANOVA. However, the 
concentration, total number of spermatozoa, and tota l number of intact 
spermatozoa decreased rapidly from the pre-vasectomy seminal collection to 
PVD 63 for both, control and treated rams ( Tables 20 and 21). The overall 
contras ts pre- versus post-vasectomy (analysis not shown in tables) were 
significant for volume of electroejaculates (P-0 . 0017), spermatozoal 
concentration (P- 0.0001), total number of spermatozoa (P-0.0001) , and 
number of intact spermatozoa ( P-0 .0001) in the electroejaculates. 
Furthermore, from day 0, the major decline in spermatozoal concentration, 
total number of spermatozoa, and total number of intact spermatozoa 
appeared to have occurred earlier for the treated rams, which had thei r 
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Table 19. Volume of the pre - and post-vasectomy electroejaculates of 
rams ( Experiment 4) 
Collection days 
Pre -vasectomy 
0 
Post -vasectomy 
3 
7 
14 
21 
28 
35 
42 
49 
56 
63 
Pre -vasectomy 
Trea t ment 
Post -vasectomy 
Treatment 
Day 
Day x treatment 
Control 
7. 6 ± 
6.3 ± 
3.8 ± 
5.0 ± 
5.0 ± 
4.6 ± 
5.0 ± 
3.2 ± 
6.2 ± 
4.9 ± 
3.8 ± 
Volume of electroe jaculate (ml) 
rams 
3.3 
2.4 
1. 8 
2.4 
3.4 
2. 1 
2 .4 
0.9 
4.3 
2.6 
1. 2 
df 
1 
1 
9 
9 
_P_ 
>0.1 
>0.1 
>0. 1 
>0 .1 
Treated rams 
4.6 ± 2.0 
3.8 ± 1. 3 
5.1 ± 2.9 
3.7 ± 1. 3 
3.8 ± 1. 8 
4 . 2 ± 1. 0 
4. 6 ± 1. 5 
3.2 ± 0.6 
3 .4 ± 0.5 
4.2 ± 0.6 
3.3 ± 0.6 
df - degrees of freedom; P - probability. Data presented as mean± 
SD; values across rams, N - 5 observations per day of collection for each 
treatment group , except for treated rams , N - 4, because of urine 
contamination of electroejaculates . 
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Table 20. Spermatozoal concen t ra tion in the pre- and post-vasectomy 
electroejaculates of rams (Expe r iment 4) 
Co llection days 
Pre-vasectomy 
0 
Post-vasectomy 
3 
7 
14 
21 
28 
35 
42 
49 
56 
63 
Pre-vasectomy 
Treatment 
Post-vasectomy 
Treatment 
Day 
Day x treatment 
Spermatozoal concentration (106 / ml) 
Control rams 
833.10 ± 410.34 
91. 07 ± 138 .19 
2.39 ± 3. 05 
0.63 ± 0.36 
0.46 ± 0. 31 
0.43 ± 0.5 1 
0 .49 ± 0. 51 
0.36 ± 0.26 
0.20 ± 0 . 15 
0. 17 ± 0.16 
0.09 ± 0.10 
df 
1 
1 
9 
9 
_P_ 
>0 . 1 
>0 .1 
>0 .1 
>0 .1 
Treated rams 
1086.55 ± 1135.55 
1.11 ± 1. 52 
0. 17 ± 0.22 
0.28 ± 0.24 
0.09 ± 0 . 09 
0.24 ± 0.13 
0.09 ± 0.07 
0.07 ± 0.06 
0.05 ± 0.04 
0. 11 ± 0.11 
0.07 ± 0.05 
df - degrees of freedom ; P - probability. Data presented as mean ± 
SD; values across rams, N - 5 observations pe r day of co llect ion for each 
t reatment group , except for treated r ams, N - 4, because of urine 
c ontamination of electroejaculates. 
58 
Tab le 21. Total number o f spermatozoa and number of intact spermatozoa in 
t h e pre - a nd post-vasectomy electroejaculates of r ams 
( Ex p e rime n t 4) 
Collec- Total No. of s 2 e r matozoa {106} No. of intact s2ermatozoa ( 106} 
ti on 
da y s Controls 
Pre-v a s-
ectomy 
0 67 63.8 
Post-vas -
ectomy 
3 642.8 
7 10 .5 
14 2.9 
21 2 . 4 
28 1. 8 
35 2.3 
42 1. 2 
49 1.1 
56 0.8 
63 0 . 4 
Pre-vasectomy 
Treatment 
Post -vase ctomy 
Treatment 
Day 
Day x trt 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
4803.0 
877 .4 
13.2 
1. 9 
1. 9 
1. 8 
2 . 4 
0.8 
0 . 7 
0.7 
0.4 
1 
1 
9 
9 
Treated 
4678.8 ± 3298.2 
5.8 
1. 7 
1.1 
1. 8 
0 . 8 
0 . 4 
0.2 
0.3 
1. 0 
0.2 
_P_ 
>0.1 
>0. 1 
>0. 1 
>0.1 
± 6.9 
± 2.0 
± 0.8 
± 3.5 
± 0 . 5 
± 0.4 
± 0 . 2 
± 0.2 
± 1. 2 
± 0.1 
Contro l s 
6678.7 ± 4709.5 
597.8 ± 
8 . 7 ± 
1. 8 ± 
1. 2 ± 
1. 0 ± 
1. 1 ± 
0.8 ± 
0.5 ± 
0.4 ± 
0.2 ± 
834.6 
11 . 3 
1. 2 
0.8 
1. 0 
1. 0 
0.6 
0.3 
0.4 
0.3 
1 
1 
9 
9 
Tr eated 
4628.9 ± 3293.2 
4 . 9 
1.4 
0.9 
1. 2 
0 . 6 
0.3 
0 .1 
0 . 2 
0.5 
0. 1 
_P_ 
>0 . 1 
>0. 1 
>0. 1 
>0.1 
± 6.5 
± 1. 8 
± 0.8 
± 2.1 
± 0 . 5 
± 0 . 3 
± 0.1 
± 0 . 1 
± 0 . 5 
± 0.1 
d f - d e grees o f f reedom; P - probability; trt - treatmen t. Data 
p r esen ted as me an± SD ; values across rams, N - 5 ob servat i o ns per day of 
collecti on fo r each trea tment group. 
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vasa deferentia flushed at the time of vasectomy, than for the control 
rams . 
The percentage of viable spermatozoa was not different (P>O. l , Table 
22) between control and treated rams on pre-vasectomy day 0, but the 
percentage of viable spermatozoa col l ected on PVD 3 tended , approaching 
significance (P-0.06, Table 22) to be lower than the percentage of viable 
spermatozoa present in the electroejaculates of the vasectomized, but not 
flushed, control rams. The x2 analysis of the ratios formed by the number 
of electroejaculates that had motil e spermatozoa in the post-vasectomy 
electroejaculates collected on PVD 3 and PVD 7 that had spermatozoa were 
not different (P>O.l, Table 22). 
Con tro l rams produced 2 azoospermic elec troe jaculates and treated 
rams produced 4 azoospermic electroejaculates during the post-vasectomy 
period (data for individual rams not shown in tables). However, none of 
the rams produced 2 consecutive azoospermic electroejaculates or even 2 
consecutive electroejaculates having only detached spermatozoal heads. 
Inspection of data presented in Tables 20 thro ugh 22 suggested that 
the number of spermatozoa, as well as the percentage of viability of 
spermatozoa and the number of elec troejaculates that had motile spermatozoa 
decreased faster for the treated than for the control rams. In addition , 
the magnitude of standard deviations for the s permatozoal end points 
(Tables 20 through 22) approached or exceeded that of the means, suggesting 
that the lack of significance was due to the variation among rams in 
response to vasectomy or to vasectomy plus flushing of the v asa deferentia . 
Thus , because of biological implications , a test of homogeneity of variance 
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Table 22. Percentage of viable spermatozoa and presence of motile 
spermatozoa in the pre- and post-vasectomy electroejaculates of 
rams ( Experiment 4) 
Collection 
days 
Pre-vasectomy 
Day 0 
Post-vasectomy 
Day 3 
Day 7 
Day 14 
to 63 
Treatment effect 
for the collec-
tion days: 0 
3 
7 
Spermatozoal 
Controls 
37. 1 ± 17. 2 
1.4 ± 1. 5 
1.1 ± 2.4 
0 ± 
df 
4 
4 
viability (%) 
Treated 
40.4 ± 9.4 
0.3 ± 0.6 
0 ± 
0 ± ... 
__E_ 
>0. 1 
-0 . 06 
ND 
Spe rmatozoal motility 
Controls Treated 
s I s s I s 
3 I 5 1 I 5 
1 I 5 0 I 4 
o I 38 o I 37 
df _E_ 
NA 
1 >0.1 
1 >0. 1 
df - degrees of freedom; ND - probability for the variance ratio not 
determined because on day 7 all of the spermatozoa in the electroejaculates 
from the treated group were dead; NA - not applicable because ratios are 
identical. 
Data for spermatozoal viability is presented as mean ± SD; values 
across rams (day 0 to 7), and values over time and across rams ( day 14 to 
63), N - 5 observations per day of collection for each treatment group, 
except for control rams on days 28 and 56, and trea ted rams on days 7, 35, 
42, and 63, for which N - 4 observations because of azoospermic 
e lectroejaculates . The df of variance ratios were established as N - 1. 
4 Probabilities for the variance ratios for the percentage of viable 
spermatozoa from the number of spermatozoa present in the electroejaculate . 
bProbabilities for x2 analysis for the ratio: number of 
electroejaculates that had motile spermatozoa from the number of 
e lectroejaculates that had spermatozoa . 
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(80) was used after the fac t (Tables 22 t hrough 24), to further define and 
determine the effect of treatment on spermatozoal concentration, number of 
intact s permatozoa, a nd on the total number of spermatozoa in t he 
electroejaculates obtained on pre -vasectomy day 0 a nd PVD 3, whic h were the 
only collection days in which viable s permatozoa were present in the 
e l ectroejaculates of both control and treated rams, a nd on PVD 7, because 
one electroejaculate from a cont r ol r am had viable spermatozoa (Table 22). 
The test of homogeneity of var i ance indicated a trend, approaching 
s ignific ance ( P-0.06, Table 23) for a higher s permatozoal concentration in 
the electroejaculates on pre - vasectomy day 0 for rams assigned to the 
treated group than for control r ams, and there was a s i gnifican t ( P<0.0001, 
Table 23) declin e on PVD 3 and again on PVD 7 (P-0.0007) due to treatment 
in the concentration of s permatozoa for the rams t ha t had their vasa 
deferentia flus h e d at the time of vasectomy. 
When a nalyzed by the test of homogeneity of variance, the total 
number of spermatozoa and number of intact s permatozoa in the 
e lectroejaculates collected on pre-vasec tomy day 0 were not differe nt 
( P>O. l , Table 24) between treatment groups. However, the total number of 
s permatozoa and number of intact spermatozoa were significantly less fo r 
the treated t han for the control rams on PVD 3 (P<0.0001, Table 24) and 
again on PVD 7 (P<0 .002). 
The relationship between the logarithmically transformed total number 
of s permatozoa in the electroejaculate and the time after vasectomy is 
shown in Figure 1. The linear equations of regression predicting the rate 
of disappeara n ce of spermatozoa (Y) from the ejacul ate as a function of the 
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Table 23. Spermatozoal concentration in the pre- and post-vasectomy 
electroejaculates of r ams until post-vasectomy day 7 
(Experiment 4) 
Spermatozoal concentration (106 / ml) 
Collection days 
Pre-vasectomy 
0 
Post-vasectomy 
3 
7 
Treatment effect 
for the collec-
tion days: 0 
3 
7 
Control rams 
833.10 ± 410.34 
91.07 ± 138.19 
2.39 ± 3.05 
3 
3 
3 
Treated rams 
1086.55 ± 1135.55 
-0.06 
<0.0001 
-0 . 0007 
1.11 ± 1.52 
0.17 ± 0.22 
df - degrees of freedom . Data presented as mean ± SD; values across 
rams, N - 5 observations per day of col l ection for each treatment group, 
except f or treated rams, N - 4, because of ur ine contamination of 
electroejaculates. For the variance ratios, df were established as N - 1 
for the lowes t component of the ratio. 
aProbabilities for the variance ratios. 
time elapsed after vasectomy (X - PVD), and the fitting of the 
logarithmically transformed data to the straight lines of regression were 
as follows: Y antilog (15.805 + (-0.063 x PVD) ) - 100 ( r-0.44, N-50 , 
P-0.0017) for the control rams, and Y - anti log [ 1 3.607 + ( -0 .042 x PVD)) -
100 ( r -0.28 , N-50, P-0.047 ) for the treated rams. The analysis of slopes 
using F test showed no significant difference ( P>O .l ) between the slopes of 
these two regress ion lines. 
The relationship between the logarithmically transformed number of 
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Table 24. Total number of spermatozoa and number of intact spermatozoa in 
the pre- and post-vasectomy electroejaculates of rams until 
post-vasectomy day 7 (Experiment 4) 
Collec-
tion 
days 
Total No. of spermatozoa (106 ) 
Controls Treated 
Pre-vas-
ectomy 
0 6763.8 ± 4803.0 4678.8 ± 3298.2 
Post-vas-
ectomy 
3 642.8 ± 877 .4 5.8 ± 6 . 9 
7 10.5 ± 13. 2 1. 7 ± 2.0 
Treatment effect df pa 
for the collec-
tion days: 0 4 >0.1 
3 4 <0.0001 
7 4 -0 . 002 
No. of intact s permatozoa (106 ) 
Controls Treated 
6678.7 ± 4709.5 4628.9 ± 3293.2 
597.8 ± 834. 6 4.9 ± 6.5 
8.7 ± 11. 3 1.4 ± 1. 8 
df pa 
4 >0.1 
4 <0.0001 
4 -0.002 
df , degrees of freedom . Data presented as mean ± SD; values across 
rams, N - 5 observations per day of collection for each treatment group. 
The df of variance ratios were es tablis hed as N - 1 . 
aProbabilities for the variance ratios. 
intact spermatozoa in the electroejaculate and t he time after vasectomy is 
shown in Figure 2. The linear equations of r egression predicting t he rate 
of disappearance of intact spermatozoa (Y) from the ejaculate as a function 
of the time e l apsed after vas ectomy (X - PVD), and the fitting of the 
logarithmically transformed data to the straight lines of regression were 
as follows: Y - antilog (15.217 + (-0.068 x PVD)) - 100 (r- 0.41, N- 50 , 
~ Control (means) 
-e- Treated (means) 
Total No. sperm (In) 
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Control (regression) 
Treated (regress ion) 
17 )l;-~~~~~~~~~~~~~~~~~~~~~~-------, 
16 
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14 
13 
12 
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1 1 
10 
9 ~~~~~~~~---'~~--'~~---'-~~-'-~~-'-~~-'-~~-' 
3 7 14 21 28 35 42 49 56 63 
Post-vasectomy day 
Figure 1. Mean values and regression lines for the rate of clearance of 
spermatozoa from the electroejaculates of control and treated 
rams (Experiment 4) 
65 
P-0 .003) for the control rams, and Y - antilog [12 . 960 + ( -0.03 7 x PVD)) -
100 (r-0.24, N-50, P<O.l) for the treated rams . The analys is of slopes 
using F test showed no s ignificant difference ( P>O. l ) between the slopes of 
these two regression lines. 
The cumulative total number of spe rmatozoa released into the post-
vasectomy electroejaculates up to PVD 63 was ( mean± SD , data not shown in 
tables) 666.l ± 888.8 x 106 spermatozoa for the control rams, and 13.3 ± 
12 .0 x 106 spermatozoa for the treated rams . The rela tionship between the 
cumulative total number of spermatozoa released into the e lectroejaculates 
and the time after vasectomy is shown in Figure 3a f or control and 3b for 
treated rams . The linear equations of regression predicting t h e increase 
in the cumulative total number of spermatozoa (Y) that had been released 
into the electroejaculates from PVD 3 to PVD 63 as a function of the time 
elapsed after vasectomy (X PVD), and the fi tting of the data to the 
straight lines of reg ression were as follows : Y (106 spermatozoa) - 649.482 
+ 0.3 14 x PVD ( r-0.01, N-50 , P>O. l ) for t h e contro l rams, and Y ( 10 6 
spermatozoa ) - 6.947 + 0.114 x PVD (r- 0.22 , N-50, P>O.l) for the treated 
rams . The fitting of the data corresponding to both treatment groups to 
quadratic regressions was also not significant (no t shown in figures or 
tables). However, the analysis of slopes u s ing F test showed a significant 
difference ( P-0.02) between the slopes of these two regressio n lines. This 
indicates that flushing the vasa deferentia at the time of vasectomy 
accelerated the clearance of spe rma tozoa from the pos t-vasectomy 
electroejaculates. 
--£--- Control (means) 
-e- Treated (means) 
No. intact sperm (In) 
66 
Control (regression) 
Treated (regression) 
11 ~~~~~~~~~~~~~~~~~~~--, 
16 
15 
14 
13 
12 
1 1 
10 
9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
3 7 14 21 28 35 42 49 56 63 
Post-vasectomy day 
Figure 2. Mean values and regression lines for the rate of clearance of 
intact spermatozoa from the electroejaculates of control and 
treated rams (Experiment 4) 
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Figure 3. Mean values and regress i on lines for the rate of increase of the cumul ative number of 
spermatozoa re l eased into the electroejacul ates of control (a) and treated (b) rams after 
vasectomy (Experiment 4) 
68 
DISCUSSION 
Overall, the results of the studies corresponding to Par t I of this 
Thesis show that xylazine induces re trograde flow of spermatozoa into the 
urinary bladder when administered to sexually rested rams and affects the 
electroejaculatory response when given to rams before electroejaculation . 
The results of Part II indicate that flushing the vasa deferentia at the 
time of vasectomy affects the rate of c learance of sperma t ozoa from the 
ejaculates of vasectomized rams. For the purpose of discussing the r esults 
of the research performed for this Thes is, the experiments are grouped as 
follows : 
Part I 
Experiment 1 . Effect of Xylazine on the Retrograde Flow of 
Spermatozoa into the Ur inary Bladder of Rams during 
Electroejaculation. 
Experiment 2. Effec t of Xylazine on the Retrograde Flow of 
Spermatozoa into the Urina r y Bladder of Sexually Rested 
Rams. 
Exper i ment 3. Effect of Xylazine on the Retrograde Flow of 
Spermatozoa into the Urinary Bladder of Sexually Rested, 
Catheterized Rams. 
Part II 
Experiment 4. Clearance of Spermatozoa from Ej aculates of Vasectomized 
Rams after Flushing the Vasa Deferentia at the Time of 
Vasectomy. 
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PART I 
Experiment 1 
The lack of an effect of treatment on volume of electroejaculate 
suggests that the administration of xylazine before EE does not influence 
the antegrade displacement and volumetric contribution of accessory sex 
gland secretions to the electroejaculate. The spermatozoal concentration 
in the electroejaculate was significantly decreased by treatment with 
xylazine, but the total number of spermatozoa in the electroejaculate was 
not affected by treatment. These results are difficult to interpret in 
view of the lack of an effect of xylazine on the volume of 
electroejaculate. An effect of xylazine on the total number of spermatozoa 
in the electroejaculate may not have been detectable because of the 
considerable variation among rams within and between treatment groups. The 
lack of an effect (P>O.l, Table 5) of week and treatment x week interaction 
support this contention. However, the percentage of retrograde flow of 
spermatozoa into the bladder was greater (P-0.017, Table 6) for the rams 
that were given xylazine before EE than for the rams of Group 1 , which were 
not given xylazine , indicating that xylazine contributed to decrease the 
number of spermatozoa in the electroejaculate. In addition, rams of Group 
1, which were not given xylazine, received an injection of tolazoline after 
EE was completed, whereas 3 of 4 rams of Group 2 were given tolazoline 
before EE in 12 of the 16 seminal collections to counteract the recumbency 
induced by xylazine. Thus , a potential counteractive effect of tolazoline 
on the spermatozoal displacement induced by xylazine during 
electroejaculation cannot be ruled out for rams of Group 2. 
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Rams of Group 1 had viable and motile spermatozoa in the first post-
EE micturition. It has been previously reported (22,23) that spermatozoa 
are present in the urine collected from the bladder of catheterized rams 
after EE or in consecutive samples of urine collected during micturition 
from rams immediately after EE or seminal collection with an AV . In the 
present experiment , the percentage of retrograde flow of spermatozoa into 
the bladder for rams of Group 1 (mean ± SD - 12 ± 11%) is comparable to the 
percentage of retrograde flow during EE previously reported (22,23). Thus, 
administration of tolazoline after EE to rams of Group 1 apparently did not 
contribute to the retrograde flow of spermatozoa into the bladder. 
The volume of urine and the concentration and total number of 
spermatozoa in the urine collected during the first post-xylazine + EE 
micturition (Group 2) or first post-xylazine micturition (Group 3) were not 
different from those of rams of Group 1. Nevertheless , administration of 
xylazine, followed by tolazoline 15 to 23 minutes after xylazine, before EE 
to rams of Group 2 resulted in an increased percentage (29 ± 18 %, 
P-0.0017, Table 6) of retrograde flow of spermatozoa into the bladder. 
This suggests that tolazoline, when given before EE, did not counteract the 
peripheral effects of xylazine on retrograde flow and may have even 
potentiated them. Administration of xylazine to sexually rested rams 
(Group 3) induced, per se and in the absence of EE, losses of spermatozoa 
in ur ine that were not different from the spermatozoal losses that occurred 
during EE i n rams in t his experiment and in previous studies (22,23). 
However, the magnitude of urinary losses of spermatozoa for rams of Group 3 
in response to xylazine and/or tolazoline treatment was erratic. 
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A potential interactive role of tolazoline and xylazine on 
spermatozoal displacement must be also taken in consideration , although it 
is difficult to interpret in view of the mixed a 1- and a 2-blocking 
properties of tolazoline, currently considered (84) as a non-selective a-
adrenoreceptor antagonist. On purely speculative basis, tolazoline may 
have counteracted the central, but not the peripheral effects of xylazine. 
Further research designed to study dose-response effects is needed to 
determine whether tolazoline exerts a counteractive effect on xylazine-
induced retrograde flow of spermatozoa into the bladder. Even though a 
potential facilitatory effect of tolazoline on the retrograde flow of 
spermatozoa into the bladder cannot be discarded at this time, an 
interactive effect of furosemide and tolazoline seems unlikely in view of a 
reported (23) lack of interference of furosemide with the ejaculatory or 
electroejaculatory responses of rams. 
The percentage of viable spermatozoa and the presence of motile 
spermatozoa in the post-treatment urine was not different between treatment 
groups, which provides additional support for an effect of both xylazine 
and EE on retrograde flow of spermatozoa into the bladder . 
Results of Experiment 1 document significant losses of spermatozoa 
i nto the urinary bladder after administration of xylazine to sexually 
rested rams or when xylazine is given to rams before EE as an aid in the 
collection of semen for the breeding-soundness examination. Because of the 
magnitude of losses of spermatozoa caused by xylazine, its use as a 
sedative to restrain rams during EE is undesirable. 
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Experiment 2 
The reduced volume of urine and decreased frequency of micturitions 
for the rams given xylazine is in disagreement with the reported (52) 
diuretic properties of xylazine in cattle. These effects could be ascribed 
to species differences in the diuretic response to xylazine, to an 
i mpairment in the evacuation of the bladder because of the recumbency 
induced by xylazine, or to inhibition of the micturition reflex in rams. 
Alpha2-mediated inhibition of bladder parasympathetic ganglia causes 
relaxation of the detrusor muscle of the bladder (85). Thus, xylazine may 
have delayed mic turition by preventing constriction of t he bladder. 
However, I observed in this experiment that the first post-xylazine 
micturition was initiated shortly after the rams stood up after the 
xylazine-induced recumbency. This micturition was often followed, almost 
immediately, by one or more short, interrupted micturitions . This 
observation seems compatible with the hypothes is t hat the decreased 
frequency of mic t uritions may have been caused by t he recumbency which 
prevented bladder evacuation. Furosemide exerts its diuretic effect 
through inhibition of reabsorption of sodium chloride in the ascendent limb 
of Henle's loop of the nephron (45). The diuretic effect of furosemide is 
thought to be mediated by prostaglandins (86), whereas o 2-adrenoreceptor 
agonists, like xylazine , induce diuresis by reversing vasopressin-induced 
wa ter retention (51). Thus , an antidiuretic, antagonistic interaction 
between furosemide and xylazine cannot be ruled out because of the design 
of this experiment. Further studies are needed to clarify a potential 
antagonistic effect of xylazine on diuresis induced by furos emide. 
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The concentration and total number of spermatozoa in the pre-
treatment urine were not different between treatment groups. The 
spermatozoal concentration in pre-treatment urine corresponded to data 
reported ( 22 ,2 3) in the literature for concentration of spermatozoa in the 
urine collected from rams immediately before ejaculation or EE. However , 
the concentration and total number of spermatozoa in the post-treatment 
urine were also not different between treatment groups. These results must 
be interpreted with caution, because the post-treatment micturitions may 
have been incomplete for the xylazine-treated rams. In addition, 
interactive effects between furosemide and xylazine may have affected the 
response to xylazine on the displacement of spermatozoa from the sites of 
spermatozoal storage. This possibility also cannot be ruled out because of 
the design of the experiment . 
The number of azoospermic collections of post-treatment urine for the 
xylazine-treated rams of Group 2 suggests an erratic response to dose of 
xylazine which could be an individual trait. For instance , one of the two 
xylazine-treated rams , that had azoospermic urine for all the collections 
in Experiment 2, was also given xylazine in Experiment 1 and its urine was 
also azoospermic in all of the 4 collections performed at that time. In 
addition, the effect of xylazine on the total number of spermatozoa in the 
urine of xylazine-treated rams in Experiment 2 appeared to be less intense 
than for the rams of Group 3 in Experiment 1, which were given tolazoline 
23 minutes after xylazine injection. Indeed, the post-xylazine urine 
obtained from the xylazine-treated rams of Group 3 in Experiment 1 
contained spermatozoa in 7 of 16 collections ( footnote in Table 6), with a 
74 
mean of 567 x 106 spermatozoa (N-16, Table 6), whereas the post-treatment 
urine obtained from the xylazine-treated r ams in Experiment 2 contained 
spermatozoa in 7 of 18 collections (footnote in Table 11 ), with a mean of 
only 25 x 106 spermatozoa (N-18, Table 11). 
The trend approaching significance (P-0.087, Table 12) for an effect 
of xylazine on the percentage of viable spermatozoa in the pos t - t rea t ment 
urine, provides additional support for an effect of xy lazine on retrograde 
flow of spermatozoa into the bladder. Even though not significant (P>O. l, 
Table 12), t here appeared to be more sampl es of post-treatment urine that 
had motile spermatozoa for the xylazine-treated (7 1%) than for the saline 
control rams (50%). Here, again, the longer exposure of spermatozoa to 
urine in the bladder due to delayed micturitions may have precluded the 
finding of more samples with motile spermatozoa in the post-treatment urine 
for the xylazine-treated rams. 
Individual or spec ies differences in the number and distribution of 
a-adrenoreceptors between the epididymides (87) and proximal and dis tal 
vasa deferentia (54) maybe influence the magnitude of spermatozoal 
displacement into the bladder in response to xylazine . Xylazine induced 
retrograde flow of spermatozoa into the bladder in the absence of any 
sexual stimulation in 9 of 10 sexually rested dogs (1). However, xylazine 
induced ex-copula ejaculation in sexually r ested stallions (47). 
Experiment 3 
The overall total volume of urine obtained during the first 60 
minutes of collection after treatment and the volumes of each sequential 
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sample obtained at 20 minutes, 40 minutes, or 60 minutes after treatment 
were significantly larger for the xylazine-treated rams of Group 2 than for 
the control rams of Group 1 . In addition, the volume of urine increased 
with time from the first to the second sequential samples taken after 
xylazine injection. These findings are consistent with the reported (52) 
diuretic effect of xylazine, but are in contrast to those of Experiment 1, 
in which no significant differences were detected, and with those of 
Experiment 2, in which the volume of urine was significantly decreased by 
xylazine. However, it must be noticed that for Experiment 3 neither 
furosemide nor tolazoline were given to the rams, and urine was obtained 
directly from the bladder. Thus, interference caused by recumbency or by 
interactive actions between furosemide, xylazine , and tolazoline did not 
play a role. 
The mean (± SD) spermatozoal concentration in the pre-treatment urine 
was 0.01 ± 0.02 x 106/ml (N - 20 observations) for rams of Group 1, and 
0.06 ± 0.10 x 106/ ml (N - 19 observations) for rams of Group 2. These 
spermatozoal concentrations are in agreement with data reported in the 
literature (22,23). For this particular comparison, but not for Tables 15 
and 16 or for the statistical analyses, one datum on spermatozoal 
concentration was discarded because it was artificially obtained by 
flushing the urinary bladder of a ram of Group 2 with saline, as explained 
in Materials and Methods. For the present experiment, the low 
concentration of spermatozoa and the occasional presence of motile 
spermatozoa in the pre-treatment urine are also consistent with the 
hypothesis (25) that the retrograde flow of spermatozoa into the urinary 
76 
bladder in sexually rested animals may be a physiological mechanism to 
discard aged spermatozoa . 
The concentration of spermatozoa in the total volume of urine 
obtained from the bladder within 60 minutes after treatment was not 
significantly different between treatment groups when analyzed by ANOVA. 
The considerable variation among rams in spermatozoal concentration, as 
evidenced by the magnitude of the standard deviations, possibly precluded 
the detection of a treatment effect on the overall post-treatment 
concentration of spermatozoa in the urine . 
There was a trend approaching significance (P-0.083, Table 15) for a 
larger total number of spermatozoa in the post-treatment urine obtained 
from xylazine-treated rams during the 60 minute period of collection than 
for the contr o l rams when data was analyzed by ANOVA. Here again, the lack 
of significance was possibly due to ram variation, as evidenced by the 
magnitude of the standard deviations. Contrast ANOVA, performed after the 
fact, de tected a significant effect of treatment on spermatozoal 
concentration and total number of spermatozoa (P-0.048 and P-0.009, 
respectively, Table 16) in the post-treatment urine for the xylazine-
treated rams. 
The post-treatment ur ine obtained during the 60 minute period of 
collection from the xylazine-treated rams in Experiment 3 contained 
spermatozoa in 15 of 20 collections (footnote in Table 15), wi th a mean of 
1471 x 106 spermatozoa (N- 20, Table 15). This response to xylazine 
treatment, regarding retrograde flow of spermatozoa into the bladder, 
resembles more closely data from xylazine-treated rams of Group 3 in 
77 
Experiment 1 (Table 6) than that from the xylazine-treated rams of 
Experiment 2 (Table 11). For Experiment 3, the response to xylazine was 
erratic for 2 treated rams, whose post-treatment urine was azoospermic in 1 
of 5 and 4 of 5 collections, respectively. 
The increased spermatozoal concentration and the increased total 
number of spermatozoa in post-treatment urine confirm that xylazine, when 
given alone, without interference from other drugs, induced retrograde flow 
of spermatozoa into the bladder of rams. The retrograde displacement of 
spermatozoa into the bladder caused by xylazine may last for a period 
longer than 60 minutes, because the samples of urine collected at 20, 40, 
and 60 minutes had spermatozoa, suggesting that the retrograde flow-
inducing effect of xylazine may continue beyond the 60 minutes of 
collection. 
No attempts were made to discard the fluid remaining in the bladder 
catheter, which may have contained part of the 4 ml of the 0.02% 
nitrofurazone solution used to fill the catheter after the last urine 
withdrawal for each collection day . Thus, a potential for a detrimental 
effect of any residual nitrofurazone on spermatozoal motility in the urine 
cannot be ignored. However, if such a detrimental effect existed, it was 
minimized because saline was infused into the bladder and then, the urine 
and saline in the bladder were evacuated. Furthermore, motile spermatozoa 
were found in the urine. The presence of motile spermatozoa in the post-
treatment urine of xylazine-treated rams provides additional support for an 
effect of xylazine on retrograde flow of spermatozoa into the urinary 
bladder, because it indicates that these motile spermatozoa were recently 
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exposed to the urine in the bladder. The conclusions inferred from data on 
the end points analyzed in the urine obtained from the bladder of rams in 
this experiment are reinforced by the fact that each pre- and pos t -
treatment collection of urine was done by first infusing saline and then 
evacuating the bladder . Thus, the spermatozoa found in each of the 
sequential samples of post-treatment urine retrograded into the bladder as 
a consequence of treatment with xylazine. 
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PART II 
Experiment 4 
The vo lume of e lectr oejaculates decreased (P-0.0017) after vasectomy 
or vasectomy plus flus hing o f t h e vasa deferentia when compared to pre-
vasectomy values. This is consistent with a previous report (65) in which 
a s ignificant reduction o f 40% to 50% in volume was r eported for ejaculates 
of rams collected with an artificial vagina between 3 hours and 6 days 
after vasectomy. The vo lume of ejaculate was unaffected fo r the control, 
sham-operated rams (65). The post-vasectomy reduction in volume of 
ejaculate is in contrast wi th previous reports fo r dogs (25,66,67) and cats 
(25,66), and probably reflects species differences in t h e volumetr ic 
contribution of seminal components from the accessory sex glands. 
The volume of the post-vasectomy elect r oejaculates from PVD 3 to PVD 
63 was not affected by flush ing of the vasa deferentia or by day of 
collection . The lack of an interaction treatment x day of co l lection 
provides additional support for the lack of an effect of treatmen t. 
The total number of spermatozoa and number of intact spermatozoa in 
t h e electroejaculates obviously decreased rapidly from the pre- to the 
first pos t-vasectomy c ollections and then decreased gradual l y to PVD 63 for 
both control and treated r a ms. However, t h e variat i on in responses among 
rams and between treatment group s on concent r ation of spermatozoa, to tal 
number of spermatozoa, and on number of intact sperma tozoa in t h e post-
vasectomy electroejaculates was cons iderable, as evidenced by the magnitude 
of t h e standard deviat i ons. This prec luded , when factorial ANOVA was used, 
the detection of an effect of treatment or of day on these end points for 
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the pos t - vasectomy electroejaculates obtained from PVD 3 to PVD 63. 
Nevertheless, the overall contrast pre- versus post-vasectomy analysis 
detected significant (P-0.0001) differences for spermatozoal concentration, 
total number of spermatozoa, and number of intact spermatozoa in the 
electroejaculates. In view of these pre- ver sus post-vasectomy 
differences, tests of homogeneity of variances were done after the fact to 
detect treatment effects for pre-vasectomy day 0, PVD 3, and PVD 7. As 
expected, the variances for these end points were homogeneous between 
control and treated rams on day 0 (Tables 23 and 24). However, the 
variances were no longer homogeneous on PVD 3 nor on PVD 7. Thus, the 
control and treated rams no longer belonged to the same population after 
the vasa deferentia of the rams from the treated group were flushed at the 
time of vasectomy. This also explains the low power of ANOVA to detect 
differences between treatment groups during the post-vasectomy period, 
because the use of ANOVA is based on the assumption of the homogeneity of 
variance (80) among treatment groups. 
The slopes of regression of data for the total number of spermatozoa 
and number of intact spermatozoa in the post-vasectomy electroejaculates 
for post-vasectomy days (from PVD 3 to PVD 63) were not different between 
control and treated rams. However, the mean of the cumulative total number 
of spermatozoa present in the electroejaculates by the end of the post-
vasectomy per iod was approximately 50 times higher for contr ol than for 
treated rams. Indeed, the slopes of the regression of cumulative total 
number of spermatozoa versus post-vasectomy days (PVD) were different 
between treatment groups, providing an additional evidence for an effect of 
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flus h ing the vasa deferentia at the time of vasectomy on the rate of 
clearance of spermatozoa from the electroejaculates of vasectomized rams. 
The prolonged presence of spermatozoa in the post -vasectomy 
electroejaculates o f control r a ms, whose vasa deferentia were not flushed, 
and that of treated rams , whose vasa were flus h e d during vasectomy, 
resembles the rate of clearance of spermatozoa from ejaculates of 
vasectomized cats (66). However, the rate of clearance of spermatozoa from 
the ejacul ates of vasectomi zed rams approaches more closely the rate of 
clearan ce o f spermatozoa from ejaculates o f men afte r vasectomy and vasal 
flushing (77) . Spermatozoa were found in smears of centrifuged samples of 
semen of men 105 days a f te r vasectomy or vasectomy and f lushing the vasa 
deferentia (77). In the present experiment, intact spermatozoa were found 
in t h e ejaculates of control and treated r ams for a l onger post-vasectomy 
period than that reported for dogs (25,67) and cats (25,66) , suggesting 
t hat a factor or factors contributed by vasa deferentia o r ampulla protects 
ram spermatozoa against head detaching. 
Flushing t h e vasa deferentia at t h e time of vasectomy reduced to zero 
the number of intact spermatozoa and detached spermatozoal heads in the 
ejaculate by PVD 6 in t he dog (25). In cats (25), flushing the vasa 
deferentia reduced t h e number of i ntact spermatozoa to zero by PVD 7, but 
detach e d spermatozoal heads were found up to PVD 49, whereas t h e non-
flushed controls had detached spermatozoa l heads by PVD 63. This 
approaches t he prolonged rate of clearance of spermatozoa from the 
ejaculates of vasectomized rams, whose vasa where flushed. Some possible 
factors involved in the delayed spe rmatozoal clearance for the ejaculates 
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of vasectomized rams could be the following. First, spermatozoa may be 
more tightly lodged to the walls of the vasa deferentia, possibly because 
of the convoluted inner surface of their well developed ampullae (14,16). 
Thus, the flushing of the vasa may have not been sufficient in vo lume or 
efficient in the strength of the jet of passing fluid to dislodge the 
spermatozoa. The vasa deferentia of men have also well developed ampullae, 
and the vasal flushing in men (77) was not as efficient as it was reported 
(25) for dogs and cats. Second , storage of spermatozoa in the vesicular 
and bulbourethral glands after vasectomy seems less likely, because 
accumulation of sper matozoa was not observed in the excurrent ducts (43,44) 
during radiographic studies in live rams, although accumulation of 
spermatozoa was found in the vesicular and bulbourethral glands of rams 
after slaughter (62). 
The rapidly decreasing mean values for total number of spermatozoa in 
the electroejaculates of treate d rams from PVD 3 to PVD 7 contrast 
dramatically (Table 21) with the means for the same period for the control 
rams. After PVD 7, the means for the remaining post - vasectomy period for 
both treatment groups appeared to decline at a similar rate . Thus, 
flushing the vasa deferentia may have washed off only those spermatozoa 
that were relatively free in the lumen of the vasa deferentia, leaving a 
population of spermatozoa that were more tightly bound to the walls of the 
vasa, which were then slowly released after vasectomy. 
Mean spermatozoal loads were estimated at post-mortem examination for 
several portions of the genito-urinary tract of intact rams (16,62), and 
these ranged from 30 to 315 x 106 spermatozoa for the ampullae of the vasa 
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deferentia, and from 99 to 164 x 106 spermatozoa f or the remainder of the 
vasa deferentia ( 16,62 ) . In another study (12), 3245 x 106 spermatozoa 
were found in the whole vasa deferentia , including the ampullae, and 5014 
to 5122 x 10 6 spermatozoa were recovered from the urinary bladder and 
urethra (12,16). In a post-mor tem examination of a single vasectomized ram 
(62) , 0.35 x 106 spermatozoa were f ound in t h e ampullae, and 0.09 x 106 
spermatozoa in the remainder of the vasa deferentia. If one estimate, from 
data reported in two of these studies ( 16 ,62), the mean spermatozoal load 
o f the vasa deferentia , including the ampullae, to be approximately 250 x 
106 , this mean would be lower t han the mean cumulative total number of 666 
x 106 spermatozoa released into the electroejaculates of the vasectomized 
control rams during the post- vasectomy co l lections up to PVD 63. This 
disparity, if real, could be explained on the basis of determination of 
spermatozoal load in necropsy specimens, retrograde flow of spermatozoa 
into the urinary bladder i nduced by death (12, 16) , or even due to increased 
spermatozoal load of the vasa deferentia before vasectomy caused by the 
immediately preceding electroejaculation. Studies on the post-ejaculation 
distribution of spermatozoa in the vasa deferentia of rabbi ts (35), and on 
spermatic flow t h rough cannulated vas deferens in r a ms ( 16 ) suggest that 
t he spermatozoal displace ment into the vas caused by the pre-vasectomy EE 
may have delayed the sperma tozoal clear ance . 
The electroejaculates of control rams had viable and motile 
spermatozoa until PVD 7, whereas for treated rams, viable and motile 
s permatozoa were found in the electroejaculates only until PVD 3 . 
Furthermore, a significantly higher number of e lectroejaculates conta ining 
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motile spermatozoa were obtained on PVD 3 from control rams than f rom 
t reated rams. 
Most of the blue-marked fluid used to flush the vasa deferentia of 
rams at the time of vasectomy r etrograded into the urinary bladder . This 
indicates t hat for anesthetized r ams , as also r eported (25) for dogs and 
cats, the pathway of least r es istance f o r the fluid flushed through the 
vasa deferentia is toward the ur i nary bladder. 
In conc lusion, flushing t h e vasa deferentia at the time of vasectomy 
acce l e r ated the rate of clearance of s permatozoa from the electroejaculates 
of vas ectomized rams, but it did not induce azoospermia by PVD 63, time at 
which the post-vasectomy collections we r e discontinued . However, flushing 
the vasa deferentia at the time of vasectomy reduced to zero b y PVD 7 t he 
presence of viable, motile spermatozoa in the elec troejaculates in the 
treated r ams, whereas the number of viable and motile spe rmatozoa was 
reduced to zero by PVD 14 in t h e control rams . 
Flushing the vasa de ferent i a was easy to pe rfo rm in rams and d i d not 
appear to induce any complication after surgery. This techn ique may hav e 
cl inical application for the s heep producer because the e lectroej acula tes 
became devoid of viable and moti l e spe r matozoa one week earlie r than 
vasectomy alone. The following modifications may i mprove the e fficiency of 
the flushing of the vasa deferentia : 1) the use of a large r gauge n eedle to 
cannulate the vasa, 2) an increase in the volume and speed of the flow of 
flushing fluid, and 3) t he use of a flus h ing fluid containing a non -
i rritant spermicidal agent. 
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SUMMARY AND CONC LUSIONS 
PAATI 
The experiments of Part I of this study showed 1) that xylazine 
induces retrograde flow of sper matozoa into the urinary bladder of sexually 
rested rams , causing urinary losses of s permatozoa that are similar to 
those induced by EE , and 2) that a dministration of xylazine to rams before 
EE contributes to decrease the number of spermatozoa in the 
electroejaculates. Urinary l osses caused by retrograde flow of spermatozoa 
into the bladder during EE decrease the number of s permatozoa in the 
ejaculate, he nce the use of xylazine as an aid in the co llection of semen 
by EE in breeding-soundness examinations is not recommended. 
PAAT II 
Vasectomy is commonl y used to render rams sterile for use as teaser 
males for detecting estrous ewes and for hastening and synchronizing t h e 
onset of estrous cyclic i ty of ewes. To safe ly use a vasectomized ram 
without the risk of inducing unwanted pregnancies , however, it is essential 
to asce rtain the time require d for the ejaculates to become azoospermic or 
devoid of viable spermatozoa after vasectomy . In addition, sh ortening the 
t ime of clearance of s permatozoa from t h e ejaculates of vasectomized rams 
increases the advantages of vasectomy for the reproductive management of 
s heep. This study showed that t he time and number of seminal collections 
after vasectomy required for t he induction of azoospermia in r ams is more 
than 9 weeks and 10 collections, respectively. Flushing the vasa 
deferentia at the time of vasectomy accelerated the rate of clear ance of 
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viable s permatozoa f rom t h e ejaculates of vasectomized rams . Flushing the 
vasa deferentia at the time of vasectomy may have cl inica l applicat i ons 
s ince this tech nique resulted in the obtainment of electroejaculates devoid 
of viable and mot ile spermatozoa one week earlier t han vasectomy a l one . 
Flushing t h e vasa deferentia is easy to perform in rams and do not a ppear 
to cause comp licati ons after surgery. 
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